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Congenital heart disease (CHD) are the most common anomaly among new-borns, it affects 
1% of live births worldwide and approximately 4,600 new-borns in the UK. Tissue engineering 
creates functional living replacements for tissues or organs with the vision to meet the demand 
for organs worldwide which in turn can help treat CHD.  
This study explored 3D bioprinting for gelatine methacrylol (GelMA), polyethylene glycol 
diacrylate (PEG-DA)-Alginate and alginate- nanocellulose (AL/N) hydrogels. Also, 
investigated cell viability and biomechanical properties for these biomaterials. 
AL/N constructs demonstrated high biocompatibility with over 80% cell viability through 21 
days. The cells in AL/N detached from constructs from day 7 and by day 21 all cells were 
found attached to the well-plate. GelMA-based constructs presented live-cells in all 
concentrations by day 21, except 20% GelMA which presented abundant cell death from day 
1. The addition of hyaluronic acid to  the 5% concentration improved biomaterial viscosity 
enabling the formation of grid-pattern constructs, reduced the overall bioprinting process time 
and presented live-cells in constructs for 21 days. PEG-DA Alginate when directly printed with 
cells presented abundant cell death from day 1. When PBS-rinsed prior to cell seeding, it 
demonstrated live cells in constructs but from day 14 most cells were dead. 
 For biomechanical properties,  AL/N and PEG-DA Alginate presented comparable results to 
native heart structures when cell-free. AL/N demonstrated significantly higher tensile strength 
and elastic potential compared to other biomaterials. The addition of cells to constructs 
reduced tensile strength and elastic potential overall. 
The change in biomechanical properties with the presence of cells suggests that the 
constructs investigated in this study are more suitable as delivery vehicles to treat damaged 
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1.1 Heart Development and structure 
Heart development is initiated with a two-layered ovoid embryonic plate, these layers stretch 
and exchange cells within themselves leading to the formation of an additional layer in 
between, the mesoderm. The cells that form the heart are derived from the mesodermal layer 
while ectoderm and endoderm are responsible for the development of the neural cavity and 
lining of organs, respectively (Moorman et al., 2003). Further growth of the embryonic plate 
creates distinctive regions of development, keeping neural tube development to an apical side 
and heart development located in the centre (Anderson et al., 2003). Folding and further 
stretching of the plate results in the formation of the known four chamber heart structure: the 
left and right atria (LA & RA), the upper chambers; and the right and left ventricles ( RV 
& LV), the lower chambers (Zaidi and Brueckner, 2017, Courtney et al., 2018). 
In a normal new-born heart, the right atrium receives deoxygenated blood from systemic 
circulation, through the tricuspid valve (Figure 1.1). The blood is directed to the right ventricle 
which contracts and directs blood to the pulmonary circulation through the pulmonary valve 
and artery (Klabunde, 2012). The pulmonary system is responsible for gas exchange, the 
fileted oxygenated blood is directed to the left atrium. Through the bicuspid valve, blood is 
delivered to the left ventricle contracting and sending oxygenated blood back to systemic 
circulation through the aorta (Levick, 2010).  
In the foetal heart, the placenta is the organ responsible for gas exchange. At this stage, lung 
function is not in use (Friedman and Fahey, 1993). Instead, most of the blood is carried away 
from the lungs through two connections: fossa ovalis (FO) and ductus arteriosus (DA, Figure 
1.2). FO is the connection between right and left atria while DA connects the aorta and 
pulmonary artery. In the foetal heart, blood is received in the RA and can either travel directly 
to the LA or directed to RV which then flows to the pulmonary artery. After birth the pressure 
in the left side of the heart increases causing DA and FO to close, these modifications are 






1.2 Congenital Heart Disease 
Congenital heart disease (CHD) are the most common anomaly among new-borns, it affects 
1% of live births worldwide and approximately 4,600 new-borns in the UK (Avolio et al., 2015). 
CHD refers to multiple conditions in which there is a malformation of vessels or, and heart 
structure. These anomalies directly influence the severity of the condition and determine if 
surgery will be required from an early stage in life (Zaidi and Brueckner, 2017). 
Septal defect is a term used for anomalies occurring within the wall that separates chambers 
in the heart. In atrial septal defects (Figure 2.1), an opening is located on the septum, in 
between atria chambers, causing oxygen-rich blood to mix with oxygen-poor blood. In most 
cases, this opening is due to the absence or incomplete closure of FO (Oreto et al., 2018). If 
the opening is small, heart repair occurs through a catheter procedure and if the opening is 
large, open heart-surgery is required (Vasquez and Lasala, 2013, Akagi, 2015). In ventricular 
septal defects (Figure 2.2.), the opening is located in between ventricles. In this scenario, the 
blood from LV travels to RV leading excess blood into the lungs causing the heart and lungs 
to work harder (Mostefa-Kara et al., 2015, Penny and Vick, 2011). If the opening is small, it 
does not affect the child and the hole will usually close over time. Large openings might cause 
murmur, and harder breathing after non-strenuous activities. In such cases, the opening is 
repaired by using pericardium or a patch to close the opening (Zhao et al., 2018, Perez-
Negueruela et al., 2017).  
 Figure 1. New-born heart depicts the four-chambered heart structure, valves and blood 
flow direction.1.2 Foetal heart demonstrates the direction of blood flow and difference in 
structure from a new-born by the presence and use of FO and DA in blood circulation. 






Single ventricle defects are anomalies that solely affect a single ventricle in the heart, 
depending on the degree of the anomaly heart function can be severely affected. In Pulmonary 
atresia, the pulmonary valve is absent or damaged, therefore the only route for blood to reach 
the lungs is through DA which closes after birth (Presnell et al., 2015). Medication to keep DA 
open is used as a form of treatment, eventually surgery is required to replace the pulmonary 
valve (Grant and Berger, 2016). In Tricuspid atresia, the tricuspid valve is absent so there is 
a reduced amount of blood that enter the heart from the circulatory system; consequently, the 
amount of oxygenated blood in the body is also reduced. Treatment for this condition involve 
multiple surgeries to maximise paths for blood oxygenation (Allen et al., 2016). Another heart 
anomaly under this category is Hypoplastic Left Heart Syndrome which is characterised by 
the under-development of the left side of the heart. In this condition the aorta and LV cavity 
are reduced in size, mitral valve is closed and the blood from RV instead is taken to the 
circulatory system via DA. Overall, HLHS is not correctable. DA can remain open using 
medication, and further operations can be done in patients. In some cases, heart transplant is 
the only treatment available (Ohye et al., 2016, Sian Pincott and Burch, 2011).   
A complex example of CHD is Tetralogy of Fallot (ToF). This defect is a combination of an 
overriding aorta (the aorta is not located at the usual position), right ventricular hypertrophy, 
pulmonary valve stenosis (narrowing of the valve) and ventricular septal defect. In this 
condition, oxygenated and deoxygenated blood mix and the amount of blood pumped to lung 
is reduced. This condition requires shunt and patch placements, and a complete repair occurs 
later as the individual matures (Apitz et al., 2009). 
The current treatments available for CHD revolve around surgery which is crucial for the 
patient’s wellbeing. Unfortunately, there are various constraints with the treatments currently 
available. In cases such as ToF, multiple surgeries are required throughout an individual’s life 
some starting soon after birth (Brickner et al., 2000). Grafts used for treatment also have 
durability restrictions and often require replacement to follow suit with the development of the 
patient. In other cases, organ transplant is the only treatment available. Organ availability is 
scarce for demand and if a transplant occurs the patient might still face organ rejection due to 
immune incompatibility (Nerem, 2010). These limitations demonstrate that superior 
therapeutic strategies are urgently required to improve and prolong an individual’s quality of 







1.3 Tissue Engineering for Cardiovascular Research 
The aim of tissue engineering (TE) is to create functional living replacements for tissues or 
organs (Berthiaume et al., 2011). The vision is to create organs fit for patient transplant, 
meeting the demand for organs worldwide. There are different approaches to tissue 
engineering: grafts, decellularisation of tissues for repopulation, 3-dimensional (3D) bioprinting 
and others (Griffith and Naughton, 2002). This project is focused on 3D bioprinting. In order to 
create a successful tissue model through 3D bioprinting, the following stages should be 
considered: imaging, design approach, biomaterial selection, bioprinting techniques, cell 
selection and application; Figure 3 (Bakhshandeh et al., 2017, Murphy and Atala, 2014). 
 
Figure 2. Congenital Heart Disease- 2.1 Atrial septal defect, the anomaly allows blood from LA to 
RA. 2.2 Ventricular septal defect, anomaly allows blood from LV to RV. 2.3 Hypoplastic Left Heart 
syndrome, underdeveloped left side of heart. 2.4 Tetralogy Fallot, misplaced aorta, narrowing of 









The use of imaging machinery helps to obtain accurate anatomical information of an organ or 
tissue (Zhang et al., 2015b). Imaging technologies such as computerised tomography (CT), 
ultrasound and Magnetic Resonance Imaging (MRI) can be used to capture the overall and 
isolated heart structure. The captured image can be coupled with 3D printing techniques 
aiming to provide a similar structure and function of tissue (Garcia et al., 2018). CT provides 
a more detailed image than a normal x-ray and the same is true for MRI, except that it does 
not make use of damaging radiation (Story and Rutherford, 2015). Ultrasounds make use of 
sound waves to obtain images. The resolution this technology provides compared to the others 
is lower, however, it is apt for printing larger structures, including heart malformation models 
through echocardiography (Picazo-Angelin et al., 2018).  
Figure 3- Considerations for 3D model creation – Imaging: CT, MRI, Echocardiography. Design 
approach: Biomimicry, self-assembly and mini-tissues. Biomaterial selection: synthetic polymers, 
natural polymers and ECM-based and CorMatrix.  Cell selection: Differentiated cells, Embryonic 
cells and multipotent cells. Bioprinting technologies: Inkjet, Laser-assisted, and Micro-extrusion. 





1.3.2 Design approach 
Biomimicry is the imitation of life or nature. This approach requires knowledge on the tissue 
and organs being duplicated but also knowledge on the environment in which the structure is 
located. As complex as it is, biomimicry can be approached at different levels by mimicking: 
function, natural processes and natural systems (Zhang, 2012).  
Mimicking function is the most common form of biomimetic. If one wants to mimic muscle 
function, a common approach is to firstly do an image analysis of the tissue. This provides 
information on the tissue structure (e.g. sarcomere) allowing angle and distance in between 
filaments measurement. Next, force analysis to calculate stress between filaments and 
surrounding structures. Followed by optical mapping and measuring transition of nutrients 
across membrane. All the information gathered can then be applied into a model being 
constructed with nanotechnology (Feinberg et al., 2012). 
Mimicking natural processes and systems is more complex. It combines not only tissue or 
organ function, but these also attempt to mimic the environment in which the structures are 
naturally located. These approaches might use bioreactors to help control the tissue 
environment. Overall, biomimetic approaches combine biophysics, cell biology, biomaterials 
and engineering in order to create successful models (Chen and Liu, 2016). 
Self-assembly uses as guidance the development of organs and tissues at embryonic level. 
Early stages of development for tissues naturally produce appropriate cell signalling and ECM. 
Therefore, if the basic embryologic anatomy is reproduced (self-assembly of cells, signalling 
patterns), development will naturally follow (Bishop et al., 2017). This approach does not make 
use of scaffolds; therefore, scaffold biocompatibility and degradation are not drawbacks (Peck 
et al., 2011). Moreover, cell attachment, interaction and ECM formation are facilitated as tissue 
development is independent on being part of a hydrogel or scaffold (Yu et al., 2016). 
Mini-tissues use as basis the smallest structure of a tissue that can be reproduced. It can 
make use of both approaches mentioned above to enlarge the construct. Mini-tissue formation 
involves self-assembly of cell spheres making use of a biologically accurate design. After the 
high-resolution design is formed, these can self-assemble into macro-tissues (Murphy and 
Atala, 2014). 
1.3.3 Biomaterial selection 
Biomaterials can be divided according to their nature; synthetic or natural. Synthetic materials 
allow more control over weight distribution and molecular weight within the construct. These 
permit easier control of crosslinking density, consequently providing more control over 




Polyethylene glycol (PEG) based materials is a common example of synthetic polymer. It is 
commonly used in research as it is FDA-approved. PEG can be chemically modified into 
polyethylene glycol diacrylate (PEG-DA) and in this form cells can be encapsulated quickly 
within the material. Construct stability is achieved by mixing PEG with a crosslinker (eg. 
Irgacure) and exposing the material to UV light. The easy chemical and mechanical 
manipulation of the material inherently leads to lack of natural proteins for cell attachment, the 
material needs to be programmed to contain attachment sites. Therefore, pairing this 
compound with natural occurring polymers such as collagen and alginate provides cell 
proliferation properties (Mazzoccoli et al., 2010). 
Pluronics also an FDA- approved synthetic biomaterial. It is non-toxic, available with a range 
of molecular weight and with different hydrophobic and hydrophilic ratios. This material 
presents thermosensitive properties, allows encapsulated cell-print and can be used as a 
scaffold material as it can be washed away easily if needed. Being an inert material, 
encapsulated cells tend to create cell-cell interaction in clusters rather than matrix-cell 
interactions in this polymer (Muller et al., 2015).  
Natural polymers include materials that can be found on the extracellular matrix (collagen, 
gelatine, hyaluronic acid) but also in non-mammalian sources (alginate, chitosan, agarose). 
These materials contain high biocompatibility which facilitates the degradation process of 
constructs by enzymes. ECM- derived polymers, contain natural attachment sites for cells 
inherently promoting cell growth and proliferation eliminating the need for further 
modifications. (Mano et al., 2007). Most naturally derived bioinks present low viscosity which 
might lead to a soft construct, with low resolution and poor shape stability. Introducing 
functional groups to the material (eg. methacrylic acid) and making use of crosslinking 
improves these limitations (Boland et al., 2007).  
Collagen is the most abundant component in the extracellular matrix, therefore is widely used 
for coating and as a bioink as it provides good cell attachment and growth factors. Collagen is 
a protein mainly located in connective tissues: bones, cartilage, tendons (Antoine et al., 2014). 
There are 16 different types of collagen in the body, 1-3 are the most abundant types. Type I 
is mostly used in TE as the extraction process is easy and it shows adaptability to different 
applications. The main sources of collagen used for bioink production are rat tail tendon, 
porcine and bovine as the structure of these are similar to humans (Avila Rodríguez et al., 
2018) 
Gelatine is derived from collagen. It is highly biocompatible, has fast degradation rate and 
non-immunogenicity. There are different types of gelatine, these vary according to the process 




medicine, Type A and B of bovine and porcine-origins are commonly used as they present 
common structure to the ones found in humans (Echave et al., 2017). 
Naturally, gelatine presents gelation characteristics at low temperatures but melts at 
temperatures higher than 35ºC. The fabrication of Gelatine- Methacrylol (Gel-MA) allows the 
overall material to withstand incubation. This compound mixture makes use of the natural 
ability of cell attachment from gelatine and uses methacrylol as a substance that allows 
material stability through the combination of a photo-initiator and UV exposure without 
compromising the overall ability of the material to adhere to cells and impact on degradation 
rate (Klotz et al., 2016, Schuurman et al., 2013). 
Hyaluronic acid (HA) can be found in lower organisms (bacteria) to complex eukaryotes. In 
the human body, HA is present in most tissue in small amounts, however on the extracellular 
matrix of soft connective tissues, synovial fluid and umbilical cord, the polymer can be found 
in greater quantities (Camci-Unal et al., 2013). This compound can enhance cell proliferation, 
differentiation and repair of tissues. It creates a porous bioink which enables easy cell 
permeability and enables growth. It also presents viscoelastic properties in tissues, good 
biocompatibility and non-toxic degradation making it a unique material for TE (Zhu, 2017).  
Alginate also presents high biocompatibility and low toxicity in biomedical applications. This 
material is obtained from brown seaweed and under mild conditions alginate can be made into 
hydrogel. It is a soluble material that supports cell growth. Alginate is uniquely composed of 
guluronic and mannuronic acid, these provide gel formation properties and increased flexibility 
of materials. This material has been used for wound healing methods and delivery of drug 
molecules extensively specifically for its ability to release reagents in a controlled manner. 
Alginate present fast gelling properties through multivalent cations (Ca²+) application (Lin et 
al., 2005). The method in which the crosslinking of alginate occurs is not fully understood, 
Typically in TE, alginate is used on the expectance of cell delivery to an injury site with the 
expectation that these will create recovery of damaged tissue (Axpe and Oyen, 2016). 
Extracellular Matrix (ECM) is present in all organs and tissues, it is highly important for cellular 
attachment and it is involved on biochemical processes such as differentiation, homeostasis 
and morphogenesis (Frantz et al., 2010). Each tissue can vary its ECM composition 
consequently changing the biomechanical properties of the compound. CorMatrix is a 
decellularised scaffold ECM-based that promotes cell proliferation and tissue regeneration. 
This material has been increasingly used for CHD research, specifically for reconstruction of 
greater vessels (Nelson et al., 2016) and as a patch for septal defects (Padalino et al., 2015). 




presented tissue calcification. CorMatrix is able to withstand pressure over 1200mmHg, 
presents no sign of calcification or immune response (Brinster and Patel, 2014). 
A biomaterial can be further classified into chemical or physical depending on the crosslink 
method of use. Chemical crosslinking is maintained through covalent bonds increasing shape 
fidelity of a model. 2-hydroxy-1-[4-(2-hydroxyethoxy) phenyl]-2-methyl-1-propanone (Irgacure 
2959) and lithium acylphosphinate salt (LAP) are commonly used substances that will capture 
UV light enabling the crosslinking. These are both water-soluble and not harmful to cells. The 
crosslinking process can occur under neutral pH, aqueous environment and room 
temperature. Physical crosslinking is maintained through hydrogen bonds, these are weaker 
interactions and possibly will not form junctions permanently. However, these are sufficient to 
keep construct from dissolving in media (Zhu and Marchant, 2011). An example of physical 
crosslinking is the gelling property of alginate using calcium mentioned previously. Natural 
polymers are typically crosslinked through physical properties (divalent cations or temperature 
change) while synthetic polymers can either be crosslinked through physical or chemical 
properties (Lin et al., 2005, Berger et al., 2004).  
1.3.4 Bioprinting 
There are three main types of bioprinter technologies: inkjet, laser-assisted and extrusion 
based bioprinting. 
Inkjet printers were initially modified from standard 2D desktop printers by replacing the ink 
cartridges with a bioink (Burke et al., 2017). This was the first technology to use specific 
position of droplet dispersion in a controlled and repeated sequence (Figure 4.1). There are 
two main methods of drop on demand inkjet printing: Thermal and Piezoelectric (Majumder et 
al., 2016). 
Thermal bioprinting uses heat to extrude the bioink material into droplets. This method creates 
a high speed of dispersion (1-10000 drops/sec) at low cost. It can use temperatures as high 
as 300°C to commence the droplet extrusion. There were concerns regarding the effect of 
such high temperatures in the material and the impact of this in cell viability, however, it has 
been shown that the increase in temperature does not affect DNA viability or stability of cells 
in the bioink being used. More interestingly the high temperature exposure only occurs for 
approximately 2us causing a 4-10°C increase in temperature of the printer head 
(Sundaramurthi et al., 2016). Thermal printing has been previously used to create a 
cardiovascular microvasculature model using endothelial cells on a fibrin-thrombin bioink. The 





Piezoelectric bioprinting makes use of acoustic waves to eject droplets. By adjusting wave 
duration, amplitude and pulse, the speed and size of the droplets can be manipulated. This 
method is slightly more advanced than thermal as it does not make use of heat and provides 
uniform size and speed of droplet extrusion. Additionally, piezoelectric printing overcomes cell 
death over shear-stress using an open pool nozzle-less ejection. Consequently, the clogging 
of nozzles is eliminated. There is however cell damage and lysis concerns linked with the 
frequency of 15-25 Hz which is used in this method (Kim et al., 2016). 
The main limitations for inkjet-based bioprinting are the difficulty to use biologically relevant 
cell density, ≤10 million cells per ml. If higher densities are used, nozzle clogging occurs and 
speed of printing decreases drastically. The viscosity of the bioink used must be lower than 
10mPas providing a  limited 3D printing capacity and poor structure stability (Derakhshanfar 
et al., 2018). 
Laser-assisted bioprinting (LAB) is based on laser-induced forward transfer which was built to 
transfer metals. This technology was improved to overcome some limitations that inkjet 
technology presented. A standard LAB device has a laser beam aimed at a ribbon (glass), the 
ribbon is covered in metallic (gold or titanium) absorbing layer film and a bioink (with or without 
cells) sits below this film layer (Figure 4.2). As the laser pulses on the ribbon, it causes the 
metallic film to evaporate and a high-pressure bubble is formed expelling the bioink into a 
collector plate in a droplet manner. This technology can also print ceramics and proteins 
(Guillemot et al., 2011).  
LAB is a nozzle-free process, being such, it overcomes the drawbacks of nozzle clogging 
presented on inkjet and it allows higher cell density concentration, 108 cells/ml. Additionally, 
the biomaterial in use can be in a solid or liquid phase, this system allows bioinks with viscosity 
from 1-300 mPa/s to be printed from a pico- to micro- resolution. To achieve good resolution 
with LAB, there are three main factors that need to be considered: 1. the distance between 
the ribbon and collector plate: if the ribbon sits too high, the droplet ejection will be less 
accurate 2. the viscosity and thickness of the biomaterial: LAB can print a range of viscosities. 
However, working with higher viscosity materials will make the resolution of the final construct 
more accurate 3. laser fluence: laser energy delivered per unit in the ribbon area (Murphy and 
Atala, 2014). 
Despite LAB providing great resolution and biologically relevant cell density for models, it is 
an expensive technology. The film coating material needs to be prepared depending on the 
cell type and biomaterial in use (bioink, proteins, ceramics). If multiple cell types are used, the 
process becomes even more costly and time consuming. Also, the vaporisation of the metallic 




Nonetheless, LAB has aided cardiovascular research by delivering mesenchymal stem cells 
on a printed grid pattern to immunodeficient rats, the technique was proven to cause functional 
improvement and induce regeneration of surrounding heart tissue (Gaebel et al., 2011).  
Extrusion-based bioprinting (EBB) is a method that uses a robotic system with x,y and z 
coordinates to produce a structure. It uses STL files to guide print also controls extrusion 
through this code system. CT files can be directly uploaded into the system and a printing 
pattern will appear instantly with this technology making it the most convenient bioprinting 
technology (Dababneh, 2014). Unlike inkjet and LAB, this method extrudes bioinks in a 
continuous form. Pressure is exerted on the piston or syringe pump controlling the printing 
speed (Figure 4.3). After or during printing process bioinks can be subjected to a form of 
crosslinking to stabilise the structure (Gao et al).  
An advantage of this method is that materials can be printed at room temperature with or 
without cells, providing a homogenous distribution throughout the construct. This method 
allows high cell density including the ability of materials to encapsulate cells spheroid for 
printing. A selection of different materials is available to use with this technology as it has a 
good range of viscosity. EBB is medium cost and simple to use making it the preferred choice 
for most labs doing small to large scale research (Bishop et al., 2017). 
The cell viability for EBB can vary from 40-80%, making it lower than inkjet and LAB. The 
viability of the encapsulated cells is also dependent on the viscosity of the material, nozzle 
diameter and pressure used in the process (Nair et al., 2009). The pressure exerted on high 
viscosity bioink with a small nozzle diameter is higher than a low viscosity bioink with a larger 
nozzle diameter. High pressure creates shear-stress causing cell death. Moreover, clogging 
often happens when the nozzle diameter is smaller than 150 µm, using a larger nozzle makes 
clogging less frequent, however it compromises the resolution of the printed structure. The 
resolution that can be achieved with this printing method is 200µm, which is considerably low 






1.3.5 Cell selection 
Cell selection is a crucial step in tissue engineering. Once the biomaterial has been 
established, the cells used on the engineered model have the potential to maximise 
resemblance to the native tissue. Initially, the use of autologous cells in combination with 
engineered models were used for reimplantation and showed great success, however the 
process is costly, invasive and can potentially collect cells which are already damaged 
(Howard et al., 2008). Stem cells have been the focus of tissue engineering because unlike 
other cells, these are unspecialised cells that are capable of indefinite self-renewal and under 
specific physiological conditions, these can be induced to differentiate into tissue-specific cells 
with unique functions (Bianco and Robey, 2001).  
Embryonic stem (ES) cells contain a pluripotent nature. ES are derived from early stage 
embryo development and are capable of proliferating indefinitely without senesce under 
specific in vitro conditions. These can uniquely differentiate into all cell types in a fully formed 
body, with the exception of placental and umbilical cord cells (Akutsu et al., 2006, Guillot, 
2010).  Adult stem cells (ASC) have a multipotent nature, these can differentiate into more 
than one cell type but are more limited than ES. ASC are tissue-specific, these generate all 
cell types of the organ from which they originated. There are various types of ASC (eg. 
endothelial, mammary, msesenchymal, neural, etc.), this review briefly focused on 
mesenchymal stem cells (Sobhani et al., 2017). 
Figure 4- Bioprinter technologies. 1. Inkjet (thermal and piezoelectric) providing constructs 
with a droplet dispersion. 2. Laser assisted bioprinting components and droplet dispersion. 
3. Extrusion based, pressure device which ejects bioink and nozzle providing a continuous 





Mesenchymal stem cells (MSCs) are spindle-like shaped when adhered to plastic and present 
a multipotent differentiation potential being able to expand over 50 doubled proliferation 
without senesce signs. These cells are mainly programmed to differentiate into three lineages 
(chondroblast, adipocytes and osteoblasts) and present a unique cell-antigen expression. 
MSCs can be obtained from a variety of tissues, these include: bone marrow, umbilical cord, 
thymus and others (Covas et al., 2008).  
Bone marrow- derived stem cells (BM-MSCs) were the first MSCs to be identified, these are 
usually extracted with a needle aspiration on the rear pelvic bone (El Omar et al., 2014). BM-
MSCs are mainly used for bone and cartilage repair as they can differentiate into osteogenic 
lineages. Being the most commonly used and characterised, BM-MSCs present therapeutic 
potential in other areas including cardiovascular research.  These cells have shown the 
potential to differentiate into cardiomyocytes by targeting overexpression of micro-RNAs 
responsible for cardiac fate and reprogramming (Fukuda, 2001, Guo et al., 2018). 
Unfortunately, BM-MSCs extraction is an invasive-painful procedure (Friedman et al., 2007) 
and the availability of these cells decrease with age (Lin et al., 2015). Due to these constraints, 
other MSCs need to be explored. 
Wharton’s Jelly (WJ) MSCs can be easily obtained through extra-embryonic tissue, the 
umbilical cord. The umbilical cord is obtained without health risks or harm. The interior 
structure has a jelly-like consistency which MSCs can be easily extracted through enzymatic 
digestion and tissue explant (Davies et al., 2017). WJ-MSCs present a fast proliferation rate, 
compared to BM-MSCs, the early passages of WJ is twice shorter for doubling cells (El Omar 
et al., 2014). Like BM-MSCs, WJ cells can differentiate into adipocytes, myocardial tissues, 
chondrocytes and others, however, the adipocyte differentiation is at a slower rate. Also, WJ 
cells have the potential to differentiate into cardiomyocytes and endothelial cells to repair 
myocardial infarction (Zhang et al., 2013).  
Thymus-derived MSCs (T-MSCs) are obtained from the thymus which is located above the 
heart and is mainly responsible for maturation of T-cells. A year from birth, the thymus reaches 
its maximum size and undergoes involution. A process that causes fibrotic changes, 
thymocyte reduction and the emergence of adipocytes (Boehm and Swann, 2013). The 
involution process finalises when an individual reaches the age of fifty, at this stage the thymus 
is composed mainly of adipose tissue. Heart repair in patients with CHD involve a thymectomy 
which allows easier access to the heart, the discarded thymus can be used for MSCs 
extraction and further research (Iacobazzi et al., 2018). T-MSCs have increasingly been used 
for tissue engineering purposes in grafts as they not only provide the usual benefits of stem 




unique features and easy accessibility, T-MSCs is a powerful therapeutic tool for tissue 
engineering research. 
1.3.6 Application 
Lastly, envisaging the application of model created is crucial, the three main applications for 
the printed constructs are: in vitro, implantation and maturation. In vitro testing refers to 
constructs which are solely designed to remain on the lab aiming to get viability data, 
biomechanical tests and structural analysis. Constructs with purpose of implantation require a 
higher standard of care than the ones in vitro as these will be transplanted into living 
organisms. The aim of implantation generally is to observe how the constructed model 
interacts in vivo and if the construct in place causes undesired immunological response. Some 
constructs require a period of maturation before implantation. This process may utilise a 
bioreactor which has the potential to mimic the body’s natural environment and this process 
is particularly beneficial for constructs which have used differentiated cells in the process 
(Murphy and Atala, 2014).  
1.4 Biomechanical properties   
After a 3D model has been created, the biomechanical properties of model can provide 
valuable information. Tensile testing is a method to assess mechanical properties of 
biomaterials. This is particularly important as it indicates if the properties of the material are 
appropriate for its intended application. Tensile machines can determine the strength of the 
material through elongation or compression, these provide a variety of results which can be 
assessed and compared with the specified target tissue (Griffin et al., 2016).  Maximum load 
and Young’s modulus are crucial measurements from elongation analysis. Maximum load (N) 
indicates the force the material can withstand before its breaking point. While Young’s 
modulus (MPa) is a measurement of the rigidity of the biomaterial by assessing the relation 
between stress and strain (Zhang et al., 2012).   
The process of testing bioinks is slightly different than tissues or vessels. In comparison, 
bioinks require considerably less force than living tissues. Most bioinks will reach failure below 
10N, therefore the appropriate machinery to test biomaterials is required to have sensitive 
sensors to present accurate analysis (Lee et al., 2018). Universal testing systems have a 
variety of components that will provide accurate measurement of samples, among all 
components the load cell and grips are the most important features. The load cell is an 
adjustable piece which should be changed dependant on the strength of the biomaterial in 
use. The same applies for the grips, low force grips are important for bioink testing and by 







TE constructs are expected to gradually mimic the mechanical and structural properties of 
native tissue. Acquiring biomechanical data on native cardiac human tissues is more 
challenging than animal models due to its limited availability. However, over the last few years 
with the emergence of TE more data has been gathered particularly for aortic and pulmonary 
valves. It is also important to compare findings of human samples with other organisms, most 
of research is carried out with animal models subsequently translated to humans (Kobayashi 
et al., 2012). Pigs are considered the most suited xenogeneic model for humans, they present 
anatomical similarities, including heart structure (Rodrigues, 2005, Crick et al., 1998) and 






Pressure  (mmHg) 
Systolic 120 130 
Diastolic 80 60 
Aortic Valve 
Maximum Load (kPa) 1740 ± 0.29 4000 ± 2.6 
Young’s Modulus (kPa) 15340 ± 3.84  1680 ± 6.5 
Thickness (mm) 1.1 ± 0.3 0.7 ± 0.4 
Pulmonary valve 
Maximum Load (kPa) 2780  ± 1.05 2740  ± 1.97 
Young’s Modulus (kpa) 16050 ± 2.02 15670 ± 8.63 
Thickness (mm) 0.397 ± 0.114 0.605 ± 0.196 
Figure 5 Tensile 
machine components: 
load frame, load cell, limit 
switch and grips. 
 
Table 1. Biomechanical properties of Human vs Porcine (Arbeiter et al., 2012, Martin and 






1.5 Vascularisation of engineered tissues 
The vascularisation of native tissue is obtained through vessel branches, capillaries, which 
redistribute blood and nutrients. This branching system allows the exchange of metabolites to 
be more efficient consequently maintaining the tissue live (Rouwkema et al., 2008). 
A major limitation of tissue engineered constructs is the lack of an inherent vascularisation 
system. If engineered tissues surpass 100-200 µm thickness, the limit of oxygen diffusion, 
nutrient exchange will not occur limiting the ability of the construct to connect to the host tissue 
(Kannan et al., 2005). Simply transferring constructs from in vivo to in vitro scenario is a 
problematic approach as blood vessel formation is a gradual process and in the meantime 
that leaves cells within the constructs susceptible to death due to lack of nutrients (Jain et al., 
2005). 
A variety of growth factors have shown to promote blood vessel formation, these factors 
promote digestion of basal membrane of a capillary which allows migration, proliferation and 
formation of new branches of vessels (Sheridan et al., 2000).  The combination of these growth 
factors within a scaffold allows vessels from nearby tissues to infiltrate the construct. This 
method also presents the time-formation limitation as the vascularisation network requires 
time to migrate. Another promising approach is the creation of arteriovenous loop enclosed by 
a polycarbonate chamber. This is a pre-vascularisation method that eradicates the need for 
growth factors while also promoting new tissue growth and providing an enclosed nutrient 
supply system within the scaffold (Lokmic et al., 2007, Laschke and Menger, 2016).  
3D bioprinting presents a great opportunity to assist on the vascularisation methods mentioned 
above. Imaging provides an accurate picture of a tissue which can be further optimised to 
provide spaces for nutrient exchange without compromising shape fidelity. Moreover, the use 
of a porous biomaterial will facilitate cell distribution, provide space for cell adhesion and 
nutrient diffusion (Ko et al., 2007). 
1.6 Study objectives 
This project aimed to explore the construction of 3D models using extrusion based bioprinting 
to produce viable scaffolds using pig derived mesenchymal stem cells implemented on 
different biomaterials. The materials used in this project were Alginate-nanocellulose, GelMA 
and PEG-DA as these have previously shown biocompatibility and desired 3D properties in 
literature. 





1. Generation of codes to instruct bioprinter the dimension of desired constructs. 
2. Code refinement to ensure shape fidelity was maintained when using different 
biomaterials and observation on the ability of constructs to withstand incubation. 
3. Implementation of cells to biomaterials and bioprinting hydrogels for cell viability and 
biomechanical assessments. 
2 MATERIALS AND METHODS 
2.1 The design of a grid pattern 
Slic3r (version 1.30-dev) was used to create a 45º grid pattern, the software provided an 
embedded 3D block model. The block was adjusted to 7.5(x), 15(y) and 2(x) mm per layer, 
the largest size prints a 12-well sized plate allows. Further adjustments were performed in the 
block design (Table 2) and the file was saved in G-code format.  
 
 
Tissue Model Settings 
Infill density 30% 
Infill pattern Grid 
Angle 45º 
Skirt loops 1 
Distance from object 0mm 
 
2.2 The design of a four-layered construct 
Following the grid patterned obtained in Slic3r, the design of multiple layers was carried on 
Repetir Host (version 2.01). The G-code file was loaded and code refinement aimed to 
provide: (I) four-layered model, (II) good shape fidelity in bioprint, (III) UV light presence 
when required and (IV) relatively fast printing. To enable g-code translation into bioprint, a 
series of commands were used to refine the code provided from Slic3r (Table 3).  
G-commands for calibration Translation 
Table 2. Design settings in Slic3r. This is a summary of the settings applied to the 
design used in all experiments in this project. These settings are found under ‘Tissue 




G21  Set units to millimetres 
G90  Use absolute coordinates 
G92  Use relative coordinates  
M83  Use relative distances for extrusion 
M84  Disable motors 
G-commands for movement  
G0  Rapid positioning in axis coordinates (x/y/z) 
G1  Controlled movement to the position in axis 
coordinates (x/y/z) 
M760  Open the valve of print-head 1 
M761  Close the valve of print-head 1 
M764  Turn on UV 
M765  Turn off UV   
G0 Z50 Moves printhead upwards 







G4 Dwell time 
 
 
2.2.1 Designing construct and deletion of incompatible commands 
Automatically upon loading the G-code an eight-layered grid construct is provided and the 
editor tab presents the full code for the construct. All layers but the first were deleted to enable 
an easier refinement process.  
The code inherently presented incompatible commands with the bioprinter in use, Inkredible. 
Therefore, the following lines of code were deleted: T0 & T1 extruder, unretract & retract, all 
lines before G21 and all lines after M84. 
2.2.2 Improving shape fidelity and speed of print 
Aiming to meet the requirements for shape fidelity, the height (z) for the first layer was set to 
0.2mm [G1 Z0.200 F700], each layer after that had a 0.3mm increase in height. Further 
refinement was performed to help prevent grid filaments from merging and repeated bioink 
dispersion in the same location. To achieve this, specific points that could potentially result in 
repeated dispersion were deleted. If certain lines within the image from the code appeared to 
Table 3. G- code commands used in the design. These commands were used in 




be in close proximity with others, it was assumed that in print this resulted in an overlap and 
therefore deletion was required. For deletion, the numbers following E (extrusion) presented 
in the code were erased (Figure 6).  
To provide relatively fast printing for constructs, the speed of print (F) was set 700mm/min. To 
implement the change, the innate number the code provided (F2400) was substituted for F700. 
2.2.3 Finalising construct 
Once the first layer was fully edited with the refinements mentioned above, the parameters of 
the code were copied over three times changing only the height (z) settings. This settings for 
constructs were used with all bioinks unless specified. 
 
 
2.2.4 UV light input 
Depending on the bioink of use, UV light was necessary to increase shape fidelity of the 
construct. In such cases after bioprinting each layer, the UV was turned on and off [M764 and 
M765]. Moreover, the exposure time (P, 
milliseconds) was added to the code (Figure 7). 
The exposure time changed dependant on the 
shape fidelity obtained for each bioink. 
Figure 7. Inclusion of UV light within 
the code. P20000 (ms) refers to the 
time the UV light was on. Time was 
changed by altering this number. M764 
and M765 are input to command the 
turning on and off of this feature.  
Figure 6. Design refinement. (a) shows the code provided by Repetir Host, the 
highlighted line is equivalent to the purple top highlighted structure in the design (b). (c) 
shows the final design of a layer after the refinement/deletion occurred. (d) represents 






2.3 10-layered intercalated construct design 
This construct was composed of a solid infill layer in the bottom and nine intercalated-grid 45 
layers. The intercalated layers were designed as an overlap from the designed model for the 
four-layered constructs (Figure 8). The overlapping was obtained through trial and error from 
the original grid 45 code. Most changes were performed on Y coordinates but few on X. The 
numbers for Y were modified until the section seemed to be in the middle of the gap from the 
original model, this method was used throughout the entire design of a layer.  
Once all parts of the construct seemed intercalated, the layers were replicated and the upper 
most layer was the original grid model. To improve shape fidelity, the intercalated layers 
changed every two layers instead of one. The solid infill was designed on Slic3r by selecting 
solid infill at 30%. This was transferred to Repetir Host and combined to the remaining 
intercalated code as the bottom layer at height (z) of 0.2mm. The solid infill created a higher 
surface of the printed design, to ensure layer stacking the heights were adjusted differently for 






2.4 Coordinates for printing in well-plates 
Inherently the code is set for a petri-dish, it was crucial to adjust it for a six- and twelve-well 
plate environment. In a twelve-well plate the initial origin is in the corner of B2, while in a six-
well plate it is located between A2 and B2. A ruler was used to measure distance from initial 
point of origin to a new desired origin and to obtain the distance between the new point of 
origin on the following well (Figure 9).  
Figure 8. 10 layers code and design. The design of the 10 layers construct 
contained a base solid infill layer, and the remaining 9 layers were intercalated grid 45 
patterns. The intercalated code was developed through trial and error. The table 






The obtained measurements were input into the code with the horizontal measurements being 
equivalent to X measurement and vertical to Y. The initial origin provided is (X-43.2, Y-26.7), 
the first new point of origin(A1) for a six well-plate is (X-40, Y20). To determine this new origin 
[G92 X0 Y0] was added to the code. Once these coordinates were added, the movement of 
print was determined by the distance of one well to the other (Table). After print of the final 
well, the code was redirected to the encrypted origin as an attempt to meet the requirement 
for a fast printing process. The same principles were applied to create the pattern for a twelve 
well-plate. 
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Figure 9. Coordinates for well plates. (a) shows the distance between wells necessary to 
modify the code to fit constructs in a 12 well-plate. (b) shows the distance between wells 
necessary to modify the code to fit constructs in a 6 well-plate. 
Table 4. Implementing measurements to code. The coordinates presented are shown 
as given by Repetir host. The inserted measurements are highlighted in bold. X refers to 




2.5 Translation of code to bioprint 
Cellink start (Cellink, US), a polyethylene oxide-based bioink and sacrificial material, was used 
to test the design properties once bioprinted. The bioink was stored at room temperature and 
extrusion pressured varied from 15-35kpa depending on nozzle diameter. 
2.6 Preparation of Bioinks 
2.6.1 PEG-DA Alginate  
13.7Mm stock solution of NaCl solution was prepared. 1% Irgacure (410896, Sigma) was 
heated at 40ºC in NaCl for 15 minutes or until a clear solution was obtained. The mixture was 
brought to room temperature. 20% Poly(ethylene glycol) diacrylate Mn700 (PEG-DA, Sigma) 
was added, mixed and filtered with a 0.2µm filter for sterility purposes. Alginate (PROTANAL 
LF 60/10, FMC) was sterilised under UV 265nm for an hour. 12.5% alginate was added to the 
solution and mixed until homogenous. UV crosslinking was used (365nm). 
2.6.2 PEG-DA Alginate-collagen 
For addition of collagen, a 316 ml 3X DMEM (Thermo Fisher, UK) solution containing 10% 
FBS was prepared. 3.6 g of high glucose, powdered DMEM was added to distilled water at 
room temperature and gently stirred. 1.04g of sodium bicarbonate was added to the medium. 
pH was adjusted to 0.2-0.3 units below the desired final working pH (7.4) by slowly adding 1M 
NaoH or 1M HCl. The pH may rise to 0.3 units upon filtration. The medium was filtered with 
0.2µm filter into sterile containers and finally FBS was added. 
0.5mg/ml of collagen was mixed with 3X DMEM solution prepared. pH was adjusted if 
necessary. This solution and PEG-DA bioink were kept on ice until they were combined. The 
collagen-3X DMEM solution composed 10% of the overall final bioink.   
2.6.3 PEG-DA Gelatine 
1% Irgacure was dissolved in NaCl (13.7Mm) at 40º C until the solution was clear. The solution 
was brought to room temperature, mixed with 20% PEG-DA and sterilised with 0.2µm filter. 
Gelatine (Type A porcine skin, Sigma), was sterilised under UV for an hour and 12.5% added 
into the solution until dissolved.  
2.6.4 Preparation of lyophilised GelMA 
Dialysis bags preparation: 12 kDa MWCO - 25mm width dialysis bags (Sigma, D9777) were 
placed under running water for 3-4 hours, that enabled glycerol removal and opening of the 




10% of gelatine was dissolved in PBS at 50ºC and stirred for 10 minutes. Methacrylic 
anhydride (MA) was added dropwise and at increased stirring speed. To achieve a high 
degree of function for the solution, 0.6g of MA was added for every 1g of gelatine used. When 
the solution became clear, after 1-2 hours of stirring, it was transferred into a 50 ml flask and 
centrifuged for 3 minutes at 3500 xg speed. The supernatant was transferred into a 200ml 
beaker and the pellet discarded. The obtained solution was mixed with double the volume of 
distilled water (40ºC) and placed in the dialysis bags.  
The dialysis bags were placed in 5L glass flask containing 40ºC distilled water. Metal stirring 
bars were placed at the bottom. The flask was maintained on top of a hot stirring plate and 
temperature checks were performed three times daily to ensure temperature was kept at 40ºC. 
The stirring speed was adjusted to ensure a gentle movement of the bags. The dialysis 
process was performed for seven days or until the solution was clear. All processes for GelMA 
preparation were carried inside a chemical safety fume hood.  
Upon dialysis completion, pH was adjusted to 7.4 with the NaOH. The solution was filter 
sterilised and transferred to 5ml tubes. The samples were snap-freezed with liquid nitrogen. 
The tube caps were pierced, and the samples were placed on a freeze dryer for 4-7 days or 
until the samples were fully dry. Dryness was achieved when the weight of the samples did 
not change from one day to the other. Standard caps replaced pierced ones to prevent solution 
being hydrated during storage. Solutions were kept on -20º C. 
2.6.5 Preparation of GelMA bioink 
The day before cell encapsulation, a 2.5mg/ml Irgacure solution was prepared by dissolving 
the powder in PBS and placing the flask on a 70ºC water bath until the solution became clear 
(5-10 mins). The solution was filtered sterilised.  
The desired concentration of GelMA was obtained by using the following calculation: 
1.25 x final desired concentration 
The desired amount of lyophilised GelMA was measured (5%, 7.5%, 10% or 20%) and PBS 
was added to four-fifths of the final volume. Irgacure was added into the solution providing a 
final concentration of 0.5%. The GelMA foam was immersed by the liquid agents, protected 
from light by using aluminium foil and left to soak overnight at 4ºC enabling full hydration. The 
following day, the flask containing Irgacure- GelMA was placed on a hot plate at 37ºC and 




2.6.6 Preparation of 5% GelMA-HA 
Following the GelMA protocol, hybrid constructs were created using hyaluronic acid as an 
attempt to facilitate bioprinting of low viscosity 5% GelMA. In the final Irgacure-GelMA solution, 
2.4% HA was added and stirred at 37ºC for 10 minutes.  
2.6.7 Preparation of Alginate-nanocellulose (AL/N) 
This bioink was obtained from Cellink and is advertised as Cellink bioink. It is crosslinked 
with ‘crosslinking agent’ which is also obtained from the company.   
2.7 Bioprinting  
Inkredible bioprinter was used for printing constructs. The device was turned on, in the panel 
‘Home Axes’ was selected. Next, the well plate was placed in the printbed and calibration of 
Z axis was performed, ‘Move Z’ was adjusted to 0.5+ in the panel. After that, the file 
containing the code could be accessed. Once selected, pressed ‘bioprint’. Extrusion 
pressure could be adjusted by turning a  knob located on the right side of the bioprinter. 
2.8 Cytotoxicity analysis of PEG-DA Alginate 
PEG-DA Alginate models (n=6) were bioprinted, crosslinked and placed directly on pig thymus 
mscs cultures in 12 well-plates. Additional PEG-DA Alginate models were bioprinted, 
crosslinked and placed on PBS for 1 and 2 days (n=6 for each day). The constructs were 
placed in cell culture after day 1 and 2 PBS rinse. Live/ Dead stain was used to analyse results. 
2.9 Determining nozzle size and extrusion pressure 
Bioinks printability was tested with different nozzle diameters: 22G, 25G and 27G. In regards 
to extrusion pressure, bioinks preferably needed to be extruded with a pressure lesser than 
30kPa.   
2.10 Optimal crosslink time 
The appropriate crosslinking time was determine through the observation of shape fidelity in 
constructs and the ability of such to withstand incubation after the crosslinking process.   
2.11 Porcine thymus mesenchymal cells isolation 
Pig thymus was rinsed twice with PBS in a petri dish, the thymus was transferred into 
another petri dish to further the cleaning process of the sample. Blood and fat lumps were 
removed with the aid of scissors and forceps to obtain a cleaner sample. The thymus was 
cut into 1cm x 1cm pieces and transferred into a tube containing 10ml of collagenase I. The 




70 µm cell stainer, in small amounts, and pressed with the base of a syringe to aid the cell 
isolation. If needed, PBS was added in small amounts to facilitate pressing through 
filter.Then, the liquid collected from the filtration process was placed into two different T-75 
flasks and medium was changed after 48 hours.  
2.12 Cell culture 
Pig thymus mesenchymal cells were cultured in Dulbeco’s Modified Eagle Medium (DMEM) 
supplemented with 10%FBS, 1% penicillin-streptomyocin; the cells were kept in a humidified 
incubator of 5% CO2 at 37ºC (Panasonic). The medium was changed every two days.  
2.13 Cell passaging  
The 10% DMEM solution was removed from the cell culture and the cells were gently 
washed with 5ml Phosphate Buffer Saline (PBS) twice. 2ml of trypsin was added to the flask 
and incubated for 5 minutes or until cells detached from the bottom of the flask. 8ml of 
DMEM was added into the incubated flask and resuspended continuously until all the cells 
were washed from the bottom. The solution was transferred into a bijou tube and placed 
under centrifugation for 5 minutes (1500 rpm, 9m·s−2, room temperature). The supernatant 
was disposed and 6ml of DMEM was added to the tube to resuspend the cell pellet. This 
solution was then placed in two different flasks, 3 ml each, and the addition of 5ml of DMEM 
was placed in each flask to obtain a total volume of 8ml in each flask. 
2.14 Cell counting  
Cell count was performed using an automated cell counter (Countess II FL) .The automated 
counter was adjusted to the specific type of cells used, porcine thymus- mesenchymal cells. 
10 µlof the total solution of the cell passaging process was taken before centrifugation and 
placed in a slide which was then inserted into the counter providing the total number of cells 
in the sample. 
2.15 Cell encapsulation 
Bioinks were placed in the incubator, 37°C, for 5-10 minutes prior to encapsulation process 
as it ensured these were in liquid state and not solid to enable mixing with cells. 
Cell encapsulation was performed by infusing 1 million cells (0.1 ml) into 0.9 ml of GelMA. The 
infused bioink was placed on ice for 5 minutes to allow the solution to become more viscous 
prior to crosslinking of each layer. Every layer was crosslinked with UV light (365nm). Medium 




Cell encapsulation for AL/N was performed in similar manner to GelMA, however 1 million 
cells were added into 1ml of AL/N bioink. The same parameter was used for PEG-DA Alginate 
without collagen. 
To mix the cells with the bioink, a cell mixer from a kit (Cellink) was used. 1ml syringe was 
used to collect the cell-infused DMEM, while a 12 ml syringe was used to collected the bioink. 
The upper part of the syringes were carefully placed on a perfectly fitted holding device. The 
extruding part of the syringes were attached to a cell mixer, which was further attached to a 
cartridge which goes into the bioprinter. Pressure was exerted on the upper part of the 
syringes to press the liquids down into the cartridge ( Figure 10). The cartridge was placed 







PEG-DA Alginate with collagen constructs were encapsulated with cells after print. Constructs 
were extruded with a syringe. Each construct used 0.25ml of bioink. After being crosslinked 
with UV, the constructs were placed in DMEM-containing cells.Each construct was placed in 
DMEM containing 250,000 cells. The well plates were placed in an orbital shaker and DMEM 
was changed after 48 hours. 
Figure 10. Cell mixer from Cellink. (a) pink fluid represents cell medium and blue 
represents bioink, both are being collected with different syringes. (b) the 
syringes are placed on holding device and then attached to cell mixing device. 





All constructs were crosslinked by UV light, except AL/N which was crosslinked using calcium 
(crosslinking agent, Cellink). The agent was placed at the end of construct bioprint (not after 
each layer) and left for 5 minutes. Agent was removed and DMEM was placed in well and 
plate was incubated.  
2.16 Cell Viability Assessment s 
DMEM surrounding constructs was removed and lived/dead stain mixture was added. The 
mixture contained standard volumes of 1000µl of 10% medium in combination with 2µl of 
ethidium bromide and 0.5µl of calcein. Constructs were incubated for 30 minutes, with 
standards of incubation of 5% CO2 at 37°C.  
Imaging was performed using Fluorescence microscope Zeiss Axio Observer z1 (Zeiss, 
Germany) with Zen Blue software. Cell viability assessments were carried at day 1,7,14 and 
21 (n=6 for each time point). The percentage of cell viability was determined through (live 
cells/ total number of cells) x 100.  
2.17 Tensile tests 
The mechanical properties of constructs were measured with a Universal Testing Machine 
(Instron, USA). The tensile properties were obtained by performing a uniaxial stretching test, 
at room temperature 25°C and constructs remained wet which helped the handling of samples. 
The speed of the crosshead was 5mm/min and the gauge length was 4.5mm. Bluehill 3 was 
used to gather information from the tensile machine and it provided the measurements for 
tensile strength at maximum load (n=6) and Young’s modulus (n=6) 
2.18 Statistical analysis 
GraphPad Prism was used for statistical analysis. All data are presented as mean ± SEM. 
Cell viability and tensile tests through the selected timepoints were assessed using one-way 
ANOVA, followed by Tukey’s post hoc test. Tensile tests comparison between constructs 
with and without cells was assessed using unpaired t-test. P values <0.05 were considered 






3.1 Translation of G-code to bioprinting using Cellink start 
To analyse printing compatibility to code, 3D constructs were initially printed using Cellink 
start. This product was ideal for code testing as it was easy to use, presented a clear colour 
which facilitated assessment of the 3D construct and the fact that further crosslinking agents 
were unnecessary made the overall construct refinement process quicker. 
It was observed that the created four-layered construct was successfully printed. It presented 
good shape fidelity and clear gaps throughout the structure which perfectly resembled the G-
code. Additionally, the codes created to adapt print into 6-well and 12-well plates were 
successful. The 10-layered construct print was not successful. The low viscosity of Cellink 
start and lack of crosslinking system interfered on the shape fidelity of a more intricate design. 




3.2 Optimal nozzle size and pressure for bioinks  
The translation of g-code into bioprinting was successful with cellink start, it was important to 
evaluate the bioprinting process with the chosen bioinks of this project. Therefore, before all 
Figure 11. From code into bioprinting. Cellink start was used initially to test the properties 
of the translation from code to bioprinting. (a) shows the successful bioprint of Grid 45 




constructs were used for cell viability and tensile analysis, extrusion assessments were 
carried. 
3.2.1 PEG-DA Alginate  
It was found that the optimal nozzle size for PEG-DA Alginate was 22G.The use of this nozzle 
allowed the printing pressure to be between 15-22 kPa also providing an overall smooth 
printing process without nozzle clogging. The 25G nozzle increased the printing pressure to 
30 kPa, consequently bioink extrusion was not continuous and a uniform construct was not 
achieved. Finally, bioink extrusion was not achieved with 27 gauge, the bioink appeared too 
viscous for extrusion in a smaller nozzle.  
3.2.2 PEG-DA Gelatine 
For PEG-DA Gelatine, print trials were performed with all nozzle sizes. However, extrusion 
was only possible with 22G at a pressure of 25-35 kPa. Extrusion of the bioink resulted in a 
3D construct external shape similar to the code design, but the internal gaps of the structure 
were undefined resulting on a solid rectangular block. 
3.2.3 GelMA 
For the bioprinting of GelMA, 22G nozzle presented uncontrolled extrusion for most 
concentrations (5%, 7.5% and 10%). The low viscosity of the bioinks resulted in merged 
filaments and undefined constructs. It was found that 25G nozzle was ideal for the bioprinting 
of 7.5%, 10% and 20% GelMA. This nozzle provided a barrier preventing uncontrolled 
extrusion and created the desired grid pattern in the structure. The optimal pressure which 
provided a smooth print without clogging was between 10-18 kPa.  Nozzle 27G required a 
higher pressure to allow extrusion, 25-30 kPa, and the bioprinting process was consistently 
extended due to nozzle clogs. Moreover, the final construct presented poor shape fidelity due 
to merged filaments. 
It was not possible to print 5% GelMA in a grid pattern and four-layered design, the bioink 
presented low viscosity and despite best efforts to maintain the construct in shape by 
attempting to slow speed of print, the filaments of the construct consistently merged. 
3.2.4 Alginate-nanocellulose (AL/N) 
The optimal pressure for AL/N was found to be 10-15 kPa using 27G nozzle. Extrusion 
occurred with other nozzle sizes, however 27G presented higher shape fidelity than the others. 
Also, 22G presented higher volume of material extrusion creating a thicker structure with 
inconsistent shape fidelity prior to the crosslinking stage. 25G nozzle presented the same 





3.3 Optimal crosslinking layer by layer 
All bioinks used in this study required a form of crosslinking. Following the success of 
establishing the optimal extrusion properties for each bioink by printing one layer, the 
crosslinking properties were tested focusing on optimal time to create a four-layer construct 
with final good shape fidelity.  
3.3.1 PEG-DA  
The crosslinking properties of PEG-DA Alginate presented optimal at a 5 seconds UV 
exposure for each layer. This parameter presented good shape fidelity for the 4 layers print 
and allowed the construct to withstand incubation without dissolution. 10 seconds of UV 
exposure for each layer also presented good shape fidelity. However, in the incubation 
process it became clear that the layers were separating which indicated a non-cohesive 
construct. 15 seconds UV exposure also created a high shape fidelity construct, but it was 
clear before incubation that the layers were individually constructed and on the incubation 
process, the layers were fully separated. 
3.3.2 PEG-DA Gelatine 
For PEG-DA Gelatine, the optimal UV exposure time was 5 seconds for each layer. Despite 
not presenting good shape fidelity, the material was able to withstand the incubation process 
with a solid and homogenous structure. In 10 seconds exposure, the construct presented signs 
of layer separation before incubation which were confirmed after incubation as the layers were 
found completely separated on the well-plate. The same applied to 15 seconds UV exposure. 
3.3.3 Optimal crosslinking time for 5% GelMA  
For 5% GelMA, various attempts were made to obtain a grid structure within the constructs 
but these were all unsuccessful. The filaments of the constructs always merged before the 
crosslinking process occurred making it difficult to achieve the desired 3D design. Instead the 
crosslinking properties were tested with the shape the biomaterial formulated once dispersed 
on the well plate. The optimal UV exposure time established for this bioink was 20 seconds 
per layer. This allowed the bioink to withstand incubation without dissolving. 15 seconds 
exposure presented a stable structure on the well plate when tilted from side to side, but the 
biomaterial completely dissolved in the incubator after 30 minutes. 10 and 5 seconds exposure 
presented poor structure stability when the well plate was tilted. The bioink was in liquid state 






3.3.4 Optimal crosslinking time for 7.5% GelMA 
It was found that for 7.5% GelMA constructs the optimal UV exposure time was 20 seconds. 
This exposure time created a grid patterned construct with homogenous layers and capable 
of withstanding incubation. 15 seconds of UV exposure presented similar features to 20 
seconds, the constructs were solid and withstood incubation for an hour, however, it was 
observed that after an overnight incubation the constructs became fragmented. 10 seconds 
exposure created a defined grid pattern but it dissolved during incubation after 30 minutes. 5 
seconds exposure for each layer resulted on solid constructs but with merged filaments. 
However, after placement in incubator these were dissolved within 5 minutes. 
3.3.5 Optimal crosslinking time for 10% and 20% GelMA 
The optimal UV exposure for 10% GelMA was 15 seconds for each layer and the same was 
found for 20% GelMA. This exposure time created a cohesive structure for both materials 
without layer separation and dissolution under incubation. 10 seconds exposure was also 
explored for these materials and despite this parameter presenting good shape fidelity and 
incubation endurance. It was observed after overnight incubation that the constructs were 
partially disintegrated. 5 seconds of incubation created defined constructs but dissolution on 
the incubation process for both 10% and 20% GelMA. 
3.4 The addition of HA to 5%GelMA 
The addition of 2.4% HA to GelMA resulted on a faster printing process overall. HA allowed 
the ice-cooling process in GelMA to be bypassed while still providing good shape fidelity. The 
uncontrolled nozzle drip which occurred with 5% GelMA concentrations was eliminated as HA 
provided the bioink a higher viscosity.  
3.4.1 Optimal nozzle size and extrusion pressure for GelMA-HA 
The printing properties of GelMA-HA presented very successful. The addition of HA to the 
bioink provided overall easier handling of the solution due to higher viscosity. This addition 
caused a slight change in the colour of the material, from a clear and transparent solution to 
a slight opaque. The optimal nozzle for printing this material was 25G at a pressure of 12-20 
kPa, these parameters allowed a solid and consistent extrusion of the bioink. Extrusion with 
22G nozzle was attempted but the bigger nozzle size created excessive extrusion of material 
even at lower pressures. In contrast, 27G nozzle presented no extrusion of material up to 40 





3.4 Final constructs and overall bioprint time 
PEG-DA Alginate presented successful shape fidelity(Figure 12 a) and the overall time to 
print a construct was 3 minutes. PEG-DA Gelatine presented a less than ideal shape fidelity 
(Figure 12 b), however it was still used to carry analysis, the overall time of print for this 
construct was also 3 minutes.  
5% GelMA presented a poor shape fidelity (Figure 12 c), but cell viability assessments and 
some tensile tests were performed.  The overall time to create 1 construct was 20 minutes. 
5%GelMA-HA (Figure 12 d)took considerably less time, 3 minutes. For all remaining GelMA 
concentrations ( Figure 12 e-g) the average time to prepare 1 construct was 25 minutes. It is 
important to highlight that the constructs were prepared in batches, therefore 6 constructs 
took 25 minutes preparation. Finally, for AL/N constructs the overall time to prepare a 
construct wa 7 minutes.  
 
 
Figure 12. (a) PEG-DA Alginate without collagen. (b) PEG-DA Gelatine. (c) 5% GelMA. 




3.5 Cell viability of PEG-DA Alginate  
At day 0 and 1 following the bioprinting of cell-seeded PEG-DA Alginate constructs, cell 
viability assessment was performed. Data was obtained through five images captured from 
each sample (n=6) in 2.5x and 20x magnification. 
PEG-DA Alginate presented 100% cell death in all constructs when observed two hours after 
the bioprinting process (Figure 13). To understand if cell death was a result of the stress from 
the bioprinting shortly followed by live and dead stain, the experiment was set again and 
analysed on day 1.The viability presented on day 1 was 100% cell death. Although, in contrast 
to day 0 all constructs were found absent of cells. Further analyses showed that by day 1 all 
cells were located at bottom of the flask rather than being held in the construct.  
 
 
Figure 13. Cell Viability Images of PEG-DA Alginate Constructs. Dead cells (red) were 
abundant at day 0 (a and b).  Assessment was done at day 1 in a repeated experiment to 
determine whether the stress from bioprinting and live/dead stain were causing death. At 
day 1 (c and d), cells were found dead, however there were no cells located within the 
construct. All cells were found on the bottom of the flask. Scale bar in a and c is 





3.6 Cytotoxicity of PEG-DA Alginate 
To analyse the factors that led to extensive cell death in PEG-DA Alginate constructs, further 
analysis with the material were carried. To determine whether PEG-DA Alginate contained 
toxic substances which caused harm to cells, printed constructs without cells were directly 
placed in cell culture. For control, untreated cells (absent of constructs) were placed in 
separate wells for analysis. 
At day 1, the control presented 100% cell viability and cells were well attached to the bottom 
of the flask (Figure 14). In contrast, cell cultures containing PEG-DA Alginate constructs at 
day 1 presented 100% cell death as seen on previous experiment. 
Following these results, further investigation on the properties of the bioink was performed. 
PEG-DA Alginate constructs (cell-free) were printed and directly placed on PBS. Constructs 
were either maintained in PBS for 1 or 2 days. After PBS rinse, the constructs were transferred 
to cell culture for one day and cell viability was analysed.  
1-day PBS rinsed constructs presented 75.78 ±3.21 % average viability at day 1 (Figure 15), 
this was found to be significantly lower than the viability for the control culture. 2-days PBS 
rinsed constructs presented 91.38 ± 2.52% viability which is significantly higher than 1-day 
PBS rinse. The cell culture for both set of experiments presented well attached cells to the 
bottom of the flask and signs of proliferation were observed. 
These results demonstrated that PEG-DA Alginate could not be used for direct bioprinting of 









Figure 14. Cell Viability Images of Cytotoxicity of PEG-DA Alginate Constructs. Viable 
cells (green) were significantly more abundant for constructs rinsed for two days (g and h) 
compared to untreated constructs (c and d). Constructs rinsed for one day (c and d) also 
showed a significant increase in cell viability compared to no untreated. A control was used 
for the experiment (a and b), one day rinsed and untreated constructs presented 
significantly lower viability compared to control. Scale bar in a, c, e, g is representative of 


































































Figure 15. Impact of PBS rinse upon PEG-DA Alginate constructs cytotoxicity. 
All assessments were performed one day after the construct was implemented into 
the cell culture. The viability of cell treated with rinsed constructs were significantly 
higher than samples treated with unrinsed PEG-DA Alginate constructs. The 
greatest viability was demonstrated with a 2 days PBS-rinse which proved to be 
similar to the average viability of the control sample. 1 day rinsed constructs 
presented a significant lower cell viability when compared to control. N=6 per time 
point. One-way ANOVA followed by Tukey’s post hoc test, *   p<0.05, ** p<0.01, *** 





3.7 PEG-DA Alginate with collagen: impact of collagen addition to the bioink 
properties 
Following information on the non-adhesive and non-absorptive nature of PEG-DA, the addition 
of collagen to the bioink was added to PEG-DA Alginate to increase cell attachment properties.  
Upon the addition of collagen, the bioink presented a lower viscosity and phase separation 
prior to printing. Due to the heterogeneous bioink, nozzle clogging was a consistent 
occurrence with all nozzle sizes. Although less frequent with 22G nozzle, a continuous bioink 
extrusion was not obtained. Despite poor shape fidelity, it was still important to assess cell 
viability upon the addition of collagen to the bioink. Therefore, a syringe was used to extrude 
0.5 ml of bioink in each well. After crosslinking under UV, the constructs still presented phase 
separation, but the cured part of the biomaterial withstood incubation allowing viability 
assessment to be performed. 
3.8 Cell Viability of rinsed PEG-DA Alginate-collagen constructs 
Following the print of PEG-DA Alginate-collagen constructs and 2 days PBS rinse, cell seeding 
was performed. 1 million cells were placed in the well of each construct, the wells were placed 
in a shaker and incubated for 24 hours (day 1). Constructs were cultured in flaks and cell 
viability assessment was performed at day 1, 7, 14 and 21. 
The average cell viability for constructs at day 1, immediately after removal from shaker, was 
found to be 75.15 ± 0.94 % (Figure 16). At day 7, the average cell viability significantly 
decreased to 65.54 ± 1.19% and for day 14, the average viability significantly decreased even 
further to 48.89 ± 1.1% compared to day 7. At day 21, a drastic decrease in viable cells was 
observed with viability presented at a 5.09 ± 1.176% average, demonstrating an overall 
significant decrease in viability and presenting over a 93% decline when compared to day 1. 
The cells were found to be distributed within the construct surface and inner parts (Figure 17). 
Most cells were located at the edges of each construct and through the time points, cell death 


































Figure 16. Average Cell Viability of PEG-DA Alginate-collagen constructs 
overtime. The average viability shows a gradual significant decline overtime with the 
lowest value at day 21 which dead cells were more abundant. N=6 per timepoint. One-








Figure 17. Cell Viability Images of PEG-DA Alginate-Collagen Constructs. Viable cells 
(green) were abundant on day 1 and 7 following the bioprinting of constructs (a-d).  At day 
14 more dead cells (red) could be seen than previous day (e and f) and day 21 showed a 
prominent increase of dead cells (g and h). Out of focus cells demonstrate the cells being 
on different planes within the constructs (b, d, f and h).  Scale bar  in a, c, e, g is 






3.9 Cell viability of PEG-DA Gelatine 
This bioink was based on PEG-DA Alginate, it was directly printed with cells without PBS rinse. 
At day 0, all cells within the construct were dead. At day 1, all cells were shown to be dead 
(Figure 18). However, in contrast to PEG-DA Alginate, the dead cells remained within the 
construct and no cells were detected at the bottom of the flask at this time point. Despite 
abundant death, it was clear that more cells were attached to constructs using this bioink than 
on PEG-DA Alginate with or without collagen. These results led to further interest on naturally 
sourced biomaterials and animal based bioinks due to enhanced cell attachment properties 





Figure 18. Cell Viability Images of PEG-DA Gelatine constructs. Dead cells (red) 
were abundant on day 0, two hours after bioprinting (a-b). The red centre in the outer 
green cells signify that all cells are dead independent of the green dye (b). At day 1, all 
cells were dead as expected to the results from day 0, however the dead cells remained 
attached to the constructs. Scale bar in a and c is representative of 500µm. Scale bar in 




3.10 Cell viability of 5% GelMA constructs 
Following the bioprinting of 5% GelMA constructs, cell viability assessments were performed 
at day 1, 7, 14 and 21 in similar manner to previous bioinks.  
The average cell viability for 5% GelMA constructs at day 1 was 81.38 ± 4.02% (Figure 19). 
At day 7, cell viability demonstrated a slight increase to 89.08 ± 2.67%, though this increase 
was no significant. At day 14, average viability was 88.28 ± 2.62% which was slightly lower 
than day 7. At day 21, cell viability slightly decreased to 87.13 ± 2.98%, not significantly. Day 




Overall, 5% GelMA presented good cell viability throughout 21 days (Figure 20). Moreover, 
the transparent nature of the material along with the flat structure formed due to unsuccessful 
3D grid pattern enabled a clearer imaging of cells within the material. At day 1, it was observed 
clear spindle-shaped cells with good spread throughout the entire surface of the material. At 
day 7, the cells appeared just as confluent and well distributed like day 1, the same was true 
for days 14 and 21. In addition to great cell viability, there were no signs of cell migration 























Figure 19. Average cell viability of 5% GelMA constructs. From day 1 to 
consecutive timepoints, the cell viability slightly increase but not significantly. N=6 per 








Figure 20. Cell Viability Images of 5% GelMA constructs. Viable cells (green) were 
abundant all throughout the timepoints. A spindle-like structure of the cells were 
observed throughout all timepoints. Scale bar in a, c, e, g is representative of 500µm. 





3.11 Cell viability for 5% GelMA-HA 
Due to the inability to obtain a 3D grid pattern with 5% GelMA, 2.4% hyaluronic acid was added 
into the solution to assist with the stability of the structure. Assessments were performed to 
determine if the addition of HA and 3D grid pattern affected cell viability. These assessments 
were performed in a similar manner to the previous experiments.  
The average cell viability for 5% GelMA-HA constructs at day 1 was 78.35 ± 3.63% (Figure 
21). For day 7, the average cell viability increased to 81.91 ± 3.28%, but this increase was not 
statistically significant. At day 14, the average cell viability was 79.77 ± 4.21% which is slightly 
lower than day 7 but the change was not found to be significant. At day 21, the average cell 
viability was 84.83 ± 3.95% which is indicated an 8.27% increase in viability when compared 
to day 1 assessment. 
The cells were distributed within the layers of the grid pattern and surface (Figure 22). During 
the 21 days of assessment the cells demonstrated good distribution, although it was difficult 
to determine the uniformity of the distribution. Moreover, cell migration did not occur from the 

























Figure 21. Average cell viability for 5% GelMA-HA constructs. From day 1 to 
consecutive timepoints, the cell viability increased but not significantly. Day 21 presented 








Figure 22. Cell Viability Images of 5% GelMA-HA constructs. Viable cells (green) 
were abundant throughout all timepoints. Out of focus images show that the cells were 
located within different planes in the constructs (b, d, f and h). Scale bar  in a, c, e, g is 





3.12 Cell viability for 7.5% GelMA 
Following the difficulty to create a 3D grid pattern with 5% GelMA, it was important to 
determine if an increase in concentration of GelMA would allow better stability of the construct. 
As previously mentioned, the increase to 7.5% GelMA was successful for shape stability. The 
next stage was to assess cell viability for this modified bioink. All assessments were performed 
at a similar manner to previous experiments. 
The average cell viability for 7.5% GelMA constructs at day 1 was 85.97 ± 2.74%. Cell viability 
gradually decreased throughout the timepoints assessed. At day 7, cell viability slightly 
decreased to 75.45 ± 3.95, this decrease was not significant. The decrease in cell viability for 
days 14 (70.85 ± 4.92%) and 21 (64.67 ± 2.06%) were considered statistically significant when 
compared to day 1. Day 21 presented the most significant decrease in viability compared to 
day 1. 
The cells were well spread within the construct layers and surface. In contrast to 5% GelMA 
imaging, the cells in this biomaterial were not captured on a spindle-shaped form. The 3D 
construct made it difficult to obtain focused images of cells in higher resolution, but this 




























Figure 23. Average cell viability of 7.5% GelMA constructs. Cell viability gradually 
decreased overtime. The change in viability was only considered significant from day 14 
onwards. N=6 per timepoint. One-way ANOVA. Followed by Tukey’s post hoc test, * 






Figure 24. Cell Viability Images of 7.5% GelMA constructs.  Viable cells (green) were 
abundant from day 1 to 14 (a, b, c, d, e and f). At day 21, some dead (cells) were 
observed. Out of focus cells demonstrate that cells were in different planes in the 
constructs (b, d, f, h). Scale bar in a, c, e, g is representative of 500µm. Scale bar in b, d, 





3.13 Cell viability for 10% GelMA  
10% GelMA constructs were cultured for 21 days and cell viability assessments were 
performed to analyse the impact of the increase of GelMA concentration in the cells. Cell 
viability presented highest at day 1 with 85.03 ± 3.48% live cells within the construct. In the 
subsequent timepoints, viability significantly decreased when compared to day 1. At day 7, 
cell viability was 72.75 ± 3.96% and at day 14, the average cell viability was 69.84 ± 2.69%. 
Day 21 presented the lowest cell viability, 58.44 ± 1.41%. In comparison to day 7, the decrease 
in viability of day 21 was significantly lower.  
Throughout 21 days the cells were well spread within the construct. Again, the cells were 
captured out of focus due to difficulty of imaging in 3D plane, but that shows that the cells were 
spread within different layers in the construct. The bottom of the flask was also observed, and 





























Figure 25. Average cell viability of 10% GelMA constructs. Cell viability significantly 
declined overtime. N=6 per timepoint. One-way ANOVA followed by Tukey’s post hoc 






Figure 26. Cell Viability Images of 10% GelMA constructs. Viable cells (green) were 
abundant mostly abundant on day 1 and 7 (a-d). At day 14 (e and f) , it was observed 
more dead cells than on previous day and the same applied for day 21 (g and h).  Out of 
focus cells demonstrate that cells were in different planes in the constructs (b, d, f, h). 







3.14 Cell viability for 20% GelMA 
At day 1, there was 100% cell death in 20% GelMA constructs. The cells were found still 




3.15 Cell viability for AL/N 
The last set of experiments focused on animal-based biomaterials. Having previously 
assessed cell viability in synthetic biomaterials, PEG-DA, it was important to analyse cell 
viability using alginate alone. AL/N was used for bioprinting constructs and cell viability was 
analysed for 21 days. 
Throughout the 21 days assessment, viable cells remained abundant. At day 1, the cell 
viability for AL/N constructs was 83.16 ± 4.03% (Figure 28). The viability presented a slight 
increase for day 7, 84.65 ± 4.38% within the constructs. Interestingly at day 7, it was observed 
that some cells had migrated to the bottom of the flask, although these were not quantified. At 
day 14, it was observed that most cells within the construct migrated to the bottom of the flask. 
Cell viability was quantified for the cells located at the bottom of the flask, 82.99 ± 5.12. At this 
time point, 62 live cells were counted within the construct and no dead cells. At day 21, even 
less cells were found within the constructs, at this timepoint cell viability for cells located at the 
Figure 27. Dead cells (red) are abundant on day 1. Scale bar  in a is representative of 





bottom of the flask was 81.21 ± 5.18%. Overall, the cell viability variance for timepoints was 
not significant.  
The imaging for AL/N constructs was performed with fluoresce and light microscopy (Figure 
29). The use of light microscopy enabled the instant feedback on cell migration prior to staining 
capturing images of cells located on the bottom of the flask Figure (c,f,I,l). Live cells were 
captured at day 1 and 7 and live cells were clearly abundant within the constructs. However, 
not many cells were seen within constructs for the following timepoints even when the 
constructs were further dissected into smaller pieces to enable easier microscope analysis. 
Fluorescence images of cells located at the bottom of the flask were captured and used for 
























Figure 28. Average cell viability for AL/N constructs. The average cell viability 
remained nearly constant. Highlighted green bars indicate the cell viability from the 
bottom of the flask as the cells migrated from the construct at that point. N=6 per 















3.16 AL/N as delivery tool for CorMatrix 
The previous results demonstrated that by day 14 all cells migrated from the alginate 
constructs to the bottom of the flask. To further explore the uses of the biomaterial, Alginate 
Cellink constructs were used as a cell delivery tool to CorMatrix. This investigation was 
Figure 29. Cell Viability Images of AL/N constructs. At day 1, viable cells (green) were 
abundant and well spread through the constructs (a-b), at this point no cell migration to the 
bottom of flask was detected (c). Day 7 presented good viability (d and e) and some signs of 
cell migration was detected (f). At day 14, not many cells remained within the constructs, 
most migrated to the bottom of the flask at that point (l and j) and the same thing applies for 
day 21 (k-n). 4x images were obtain through light microscopy while 2.5x and 20x were 
obtained through fluorescence microscopy. Out of focus cells demonstrate that cells were 
located in different planes in the constructs (b, e, h, l). Scale bar  in a, c, d, f, g, i, j, k, m and 





performed to assess cell viability and to analyse cell spread through the surface of CorMatrix. 
The assessments were performed at day 14. 
At day 21, cell viability for cells within the area of CorMatrix was 98.02 ± 3.98%. The cells 
presented a clear spindle-like shape although in proximity to adjacent cells. It was observed 
that most cells which migrated from alginate constructs preferred to stick to the bottom of the 
flask rather than the CorMatrix. Moreover, most cells that attached to CorMatrix did not present 
good spread throughout the surface. The cells mainly attached to two apical edges of the 
CorMatrix, leaving the centre completely absent of cells. 
 
Figure 30. Cell Viability Images of CorMatrix. At day 14, cell migration occurred from 
alginate construct into the CorMatrix as expected. Viable cells (green) were abundant (a) 
and presented a spindle-like structure (b). Cell distribution within the CorMatrix was poor 
as the cells attached to the corners of the material, leaving the middle absent of cells (c). 
Scale bar in a representative of 500µm. Scale bar in b is representative of 50µm. Scale bar 






3.17 Cell viability of 10-layered AL/N constructs in Non-Adherent Plastic Well 
 All cell viability assessments were previously performed in 4 layered constructs. Further 
investigation of cell viability in larger constructs is important as it provides insight whether 
tissue engineered constructs can sustain live cells for a relevant time period. Therefore, 10 
layered Alginate Cellink constructs were created and bioprinted directly with cells in an 
intercalated grid pattern shape. Moreover, given the previous results demonstrating cell 
migration from constructs with Alginate, non-adherent well plates were used to observe cell 
migration. Cell viability and migration were assessed in a similar manner to previous 
experiments. 
At day 1, the average viability presented for 10 layered ‘Cellink bioink’ constructs was 84.26 ± 
3.16%. At day 7, the cell viability slightly increased to 84.3 ± 3.42 and suffered a slight 
decrease at day 14 which showed 81.79 ± 2.96% cell viability (Figure 31). At day 14 all cells 
were found in suspension (Figure 32). The slight variances in cell viability were not considered 
























Figure 31. Average cell viability for 10 layered Alginate constructs. The average cell 
viability presented no significant changes from day 1-14. However, at day 21 all cells were 








Figure 32. Cell Viability Images of 10 layered Alginate constructs. Viable cells (green) 
were abundant from day 1 until 7 within constructs (a-d). At day 14, all cells were found in 
suspension and by day 21 all cells were dead (red). Out of focus cells demonstrate that 
cells were in different planes in the constructs (b and d). Scale bar in a, c, e, g is 





3.18 Biomechanical analysis of PEG-DA Alginate constructs  
It has been previously determined that PEG-DA Alginate required PBS rinse to provide a 
suitable environment for cell survival. Also, it was mentioned that without the presence of 
collagen, PEG-DA is non-absorptive leading to poor cell attachment. Following this 
information, biomechanical assessments for PEG-DA Alginate constructs were performed 
solely on cell-free constructs. It was important to obtain this information as PEG-DA Alginate-
collagen constructs did not provide good shape fidelity. 
The average tensile strength presented by PEG-DA Alginate constructs was the highest at 
Day 1 showing 1956 ± 119.1 kpa (Figure 33). In the subsequent time points, tensile strength 
significantly decreased over 60% from the initial value obtained. Day 21 presented the lowest 
average tensile strength, 562.5 ± 20.92 kpa. There was no significant difference in tensile 
strength among day 7, 14 and 21. 
In addition to the tensile strength, the elasticity potential of PEG-DA Alginate was analysed. 
Overall, there were no significant variations on the elasticity potential shown by this 
biomaterial. At day 1, the average Young’s Moduli was 145.2 ± 49.75 kpa, the Modulus for the 





Figure 33. Biomechanical properties of PEG-DA Alginate constructs.Tensile 
strength at Maximum load significantly decreased overtime (a). The elasticity potential 
of the material also decreased overtime however not significantly (b). N=6. One-way 






3.19 Biomechanical analysis of 5% GelMA constructs  
As previously recorded, 5% GelMA constructs were unable to present the desired 3D grid 
pattern. Despite the poor shape fidelity on the structure obtained, biomechanical properties 
for the biomaterial without cells were obtained.  
The average tensile strength for 5% GelMA constructs at day 1 was 151.7 ± 54.75 kpa (Figure 
34). In the subsequent time points the tensile strength decreased for the constructs but not 
significantly. The lowest value for tensile strength was obtained at day 21, 103.21 ± 7.64 kpa. 
The elastic properties of the material were also analysed. At day 1, the average Young’s 
moduli was 41.64 ±11.14 kpa. At day 7, the values obtained for Young’s modulus slightly 
increased to 50.41 ± 3.61. In the following time points, the elastic properties recordings 
decreased. The lowest modulus obtained was at day 21 presenting a 24.13 ± 2.29 kpa, this 





Figure 34. Biomechanical properties of 5% GelMA constructs. Tensile strength of the 
constructs deceased overtime, however the decrease was not significant (a). The 
elasticity of the material decreased overtime and day 21 presents a significantly lower 
elasticity potential when compared to day 7 (b). N=6 per time point. One-way ANOVA 





3.20 Tensile strength at Maximum Load for 5% GelMA-HA constructs with and 
without cells 
5% GelMA- HA constructs have previously presented good shape fidelity before and after cell 
incorporation within the structure. Biomechanical properties were analysed for this biomaterial 
in a similar manner as the previous tested materials. Further, the analysis was carried with 
and without the presence of cells within the construct to obtain information on the effect of 
cells on tensile strength and elastic properties in a construct.  
The tensile strength for 5% GelMA-HA constructs without cells was highest at day 1 presenting 
an average of 958.9 ± 236 kpa strength (Figure 35). In the following time points, the tensile 
strength of the constructs gradually decreased, however, not significantly. Day 21 presented 
the lowest tensile strength, 621.1 ± 65.29 which shows approximately a 65% decrease in 
strength compared to day 1.  
The tensile strength for 5% GelMA-HA constructs with cells was also highest at day 1 
presenting a 438.6 ± 112.1 kpa strength at maximum load. The subsequent time points 
demonstrated a gradual decrease in tensile strength of the constructs, however these 
variations were not considered statically significant. Day 21 also presented the lowest tensile 
strength, 153.9 ± 47.45 kpa which is approximately a 64.9% decrease in strength compared 
to day 1. 
The comparison at day 1 of tensile strength between constructs with and without cells 
demonstrated that 5% GelMA-HA constructs with cells present lower tension endurance than 
constructs without cells. Although, the constructs containing cells presented 54.2% decline in 






3.21 Young’s Modulus for 5% GelMA-HA constructs 
The elasticity potential of 5%GelMA-HA constructs without cells showed the highest at day 1 
with 184.0 ± 12.93 kpa (Figure 36). The modulus decreased over time reaching the lowest at 
day 21, 100.8 ± 16.26 kpa, which was significantly lower compared to day 1. The decrease in 
the elastic potential of the constructs was not considered significantly different from day 7 to 
21.  
5% GelMA-HA constructs with cells showed a similiar gradual decrease to the constructs 
without cells. At day 1, the average moduli was 88.61 ± 25.67 kpa and in the subsequent time 
points the elastic potential decreased but these variances were not considered statistically 
significant. Day 21 presented the lowest elasticity potential, 29.44 ± 15.14 kpa. 
The day 1 comparison of the constructs with and without cells demonstrated that the presence 
of cells within the biomaterial significantly decreases the elasticity potential of the constructs. 
Figure 35. Tensile stress at Maximum Load for 5% GelMA- HA constructs with and without 
cells. Tensile strength decreases overtime for constructs with and without cells (a,b). Day 1 
comparison shows that the tensile strength of construct with the presence of cells is reduced, 
however this decrease is not quite significant (p=0.0745, c). One-way ANOVA was used for 
analysis of construct with and without cells overtime. Unpaired t test was used for day 1 





Constructs without cells presented an approximate 52% decrease in its elasticity potential 





3.22 Tensile strength at Maximum Load for 7.5% GelMA constructs  
For 7.5% GelMA constructs without cells, the average tensile strength presented at day 1 was 
1416.1 ± 54.44 kpa (Figure 37). At day 7, the tensile strength decreased to 1175.2 ± 295.7 
kpa, but at day 14 the values obtained for tensile strength slightly increased to 1356.6 ± 76.44 
Figure 36. Young’s Modulus of 5% GelMA-HA for constructs with and without cells.The 
elasticity capacity of the constructs gradually decreased overtime with the difference only 
being significant at day 21 (a). For constructs with cells the decrease was gradual, however 
not significant (b). The day 1 comparison showed that the presence of cells decreases the 
elasticity capacity of the constructs significantly (c). N=6 per timepoint. One-way ANOVA 
followed by Tukey’s post hoc was used for analysis of moduli overtime. Unpaired t-test was 





kpa. Day 21 presented the lowest tensile endurance with 1132.4 ± 115.2 kpa. All the variances 
in tensile strength for these constructs were not considered statistically significant.  
Following investigation, constructs containing cells demonstrated decreased tensile strength 
compared to constructs without cells. 7.5% GelMA constructs with cells presented 356.0 ± 
3.42 kpa tensile strength at day 1. The subsequent time points demonstrated a gradual 
decrease in tensile strength, however this decrease on strength was considered significant 
from day 14 onwards. At day 14 the tensile strength was 185.7 ± 49.73 kpa, followed by a 
further significant decrease in construct strength on day 21 which presented 110.0 ± 43.21 
kpa.  
The day 1 comparison between 7.5% GelMA constructs with and without cells demonstrated 
that the presence of cells within the constructs significantly decrease the tensile strength by 
approximately 75%.  
 
 
Figure 37. Tensile stress at Maximum Load of 7.5% GelMA constructs with and 
without cells.The tensile strength for constructs without cells presented no significant 
changes overtime (a). Constructs with cells showed a gradual decrease in tensile 
strength overtime with a significant decrease on days 14 and 21 (b). Day 1 comparison 
demonstrated that the presence of cells significantly decreases the tensile strength of the 
constructs (c). N=6 per timepoint. One-way ANOVA was used for analysis of constructs 
with and without cells overtime, Tukey’s post hoc test was used for constructs with cells. 
Unpaired t-test was used for day 1 comparison. *p<0.05, **p<0.01, ***p< 0.0001. Data 






3.23 Young’s Modulus for 7.5% GelMA constructs 
The average moduli for 7.5% GelMA constructs without cells at day 1 was 183.1 ± 22.9 kpa 
(Figure 38). In the following time points, the elasticity capacity of the constructs decrease but 
the changes were not statistically sigificant. The lowest elasticity potential was recorded at day 
21, which showed a moduli of 131.0 ± 17.30 kpa.  
For 7.5% GelMA constructs with cells, the best elasticity potential was at day 1 which showed 
a moduili of 95.24 ± 7.64 kpa. The elasticity potential of the constructs decreased overtime 
and this decrease was deemed signficant starting at day  14 which presented a moduli of 
37.30 ± 10.70kpa. The lowest elasticity capacity was shown at day 21  with a moduli of 27.24 
± 5.29 kpa, this was considered significantly lower than the elasticity shown at day 1 and 7. 
The day 1 comparison for this biomaterial also showed that the presence of cells significantly 
decreases the elasticity potential of the constructs. The presence of cells within the constructs 
caused an approximate 47.98% decrease in elasticity.
 
 
Figure 38. Young’s Modulus of 7.5% GelMA constructs with and without 
cellsConstructs without cells showed a gradual decrease on the elasticity, however not 
significant (a). Constructs with cells showed a decrease in elasticity significantly (b). The 
day 1 comparison demonstrated the significant decrease in elasticity the presence of 
cells cause to constructs (c). N=6 per time point. One-way ANOVA was used for 
analysis of constructs with and without cells overtime. Unpaired t-test was used for day 






3.24 Tensile strength at Maximum Load for 10% GelMA constructs 
 Overall the tensile strength presented by 10% GelMA constructs without cells did not present 
any significant differences (Figure 39). At day 1, the average value for tensile strength 
obtained was 1383.7 ± 74.20 kpa. At day 7, the tensile strength slightly decreased to 1073.2 
± 317.7, however at day 14 the values obtained for tensile strength were slightly higher, 1265.8 
± 101.1 kpa. At day 21, the average tensile strength presented was 1086.3 ± 122.5 kpa. 
For 10% GelMA constructs with cells, the tensile strength significantly decreased overtime 
compared to day 1. The highest value for tensile strength was presented at day 1, 413.7 ± 
41.52 kpa. In the subsequent time points, the tensile endurance of the constructs decreased 
and the lowest recorded strength was at day 21 with 139.5 ± 45.19 kpa.  
The day 1 comparison for 10% GelMA constructs with and without cells demonstrated that the 
presence of cells significantly decreases the tensile endurance of constructs. The disparity in 
tensile strength obtained at day 1 comparison was of 70%. 
 
 
Figure 39. Tensile stress at Maximum Load of 10% GelMA constructs with and 
without cells.The tensile strength for constructs without cells presented a decrease, 
however not significantly (a). Constructs with cells presented an overall significant 
decrease overtime in comparison to day 1 (b). The day 1 comparison highlighted the 
significant decrease in strength cells cause to constructs (c). N=6 per time point. One-
way ANOVA followed by Tukey’s post hoc test was used for analysis of constructs with 
and without cells overtime. Unpaired t-test  was used for day 1 comparison, *** P<0.001. 






3.25 Young’s Modulus for 10% GelMA constructs 
The elasticity potential of 10% GelMA constructs without cells did not significantly varied on 
the analysed time points. The highest elasticity potential was shown at day with a moduli of 
184.4 ± 23.10 kpa (Figure 40). In a similar manner to previous biomaterials analysed, the 
elasticity potential of these constructs also decreased overtime. The lowest elasticity 
potential was shown at day 21 with a moduli of 132.10 ± 17.44 kpa. 
For constructs with cells, there was an overall significant decrease on elasticity potential 
overtime when compared to day 1. At day 1, the moduli obtained was 103.9 ± 12.43 kpa 
which showed the highest elasticity potential. Day 21 showed the lowest elasticity potential 
with a recorded moduli of 49.78 ± 5.53 kpa. 
The day 1 comparisons showed again that the presence of cells decreases the overall 
elasticity potential for the constructs. The integration of cells within 10% GelMA caused a 
significant 43.65% decrease in its elasticity potential. 
 
 
Figure 40. Young’s Modulus of 10% GelMA constructs with and without 
cells.Constructs without cells showed a gradual decrease on elasticity, but not 
significantly (a). In contrast, constructs with cells showed a significant decrease in 
elasticity overtime (b). The day 1 comparison showed a significant decrease in elasticity 
for constructs with cells (c). N=6 per time point. One-way ANOVA was used for analysis 
of constructs with and without cells. Unpaired t-test used for day 1 comparison, *   






3.26 Tensile strength at Maximum Load for AL/N constructs  
AL/N constructs without cells presented an average tensile strength of 2981.17 ± 463.9 kpa 
at day 1. The tensile strength presented a gradual decline over the subsequent time points. 
At day 7, the tensile strength slightly decreased to 2320 ± 89.30 kpa but not significantly 
(Figure 41). At day 14, the tensile strength recorded for constructs further decreased to 1748.3 
± 104.7 kpa, this was considered significant lower in comparison to day 1. The lowest values 
for tensile endurance were presented at day 21, 1250.1 ± 76.74 kpa. The tensile strength for 
day 21 was significantly lower when compared to day 1 and day 7. 
AL/N constructs containing cells presented an average tensile strength at day 1 of 1823.8 ± 
369.7 kpa. After day 1 the tensile strength of the constructs decreased overtime, but this 
decrease in strength was only considered significant starting on day 14. At day 14, the average 
tensile strength presented was 785.9 ± 80.27 kpa which was significantly lower when 
compared to day 1. Moreover, day 21 also presented a significant decrease in tensile strength 
when compared to day 1, 660.8 ± 52.82 kpa. 
The day 1 comparison between constructs with and without cells demonstrate that the 
presence of cells significantly decreases the tensile strength of the constructs. For AL/N 








3.27 Young’s Modulus for AL/N constructs 
The highest elastic potential for Alginate constructs without cells was presented at day 1 with 
a modulus of 400.3 ± 119.8 kpa (Figure 42). The elasticity potential decreased overtime 
however the variances were not deemed statistically signficant. The lowest elasticity potential 
was presented at day 21 with a moduli of 176.1 ± 14.84 kpa. 
For constructs with cells, the elasticity potential decreased in a similar manner seen to 
previous biomaterials overtime, but this decrease was not considered significant. The highest 
elastic potential for alginate constructs with cells was shown at day 1 with a modulus of 241.3 
Figure 41. Tensile strength at Maximum Load of AL/N constructs with and without 
cells. Constructs without cells presented a significant decrease on tensile strength 
overtime (a). Constructs with cells also presented a significant decrease in tensile 
strength overtime (b). Day 1 comparison showed how the presence of cells significantly 
decreases the strength of constructs (c). N=6 per timepoint. One-way ANOVA followed 
by Tukey’s post hoc test for analysis of constructs with and without cells overtime. 
Unpaired t-test was used for day 1 comparison, * P<0.05, **  P<0.01, *** P<0.001. Data 




± 68.27 kpa. At day 21, the lowest elastic potential was obtained with a moduli of 110.2 ± 14.0 
kpa. 
The day 1 comparison for constructs with and without cells demonstrated that the presence of 
cells within alginate constructs does not affect the elasticity potential of the biomaterial 
significantly. Despite not significant, the presence of cells caused a 39.72% decrease on the 
elasticity potential of the constructs.   
 
 
3.28 Scanning Electron Microscopy 
The structure of the constructures varied (Figure 43). PEG-DA Alginate seemed to have the 
most distinct characteristics compare other constructs. The pores for this biomaterial does not 
look as crumbly as the others. 5% and 7.5% GelMA seem to have similar structure, fibre-like 
and crumbled. The same applies for AL/N constructs, except that the space in between pores 
seem wider. 
Figure 42. Young’s Modulus of Alginate Cellink constructs with and without cells. 
Constructs with (b) and without cells (a) showed a gradual decrease in elasticity 
capacity, however not significantly. Day 1 comparison demonstrated that the presence of 
cells decrease the elasticity of constructs but not significantly (c). N=6 per time point. 
One-way ANOVA was used for analysis of constructs with and without cells overtime. 








Tissue engineering provides different methodologies to aid with CHD treatment, 3D bioprinting 
transformed the field of TE as it provides approaches which are speedy, controlled and precise 
compared to other manufacturing methods available (Yu et al., 2018). This project focused on 
Figure 43. Representative SEM imaging of constructs (a) Images of PEG-DA Alginate 
with collagen constructs shows the pores within the structure of the biomaterial. (b) Shows 
7.5% GelMA fibre-like structure with gap in between, the same applies for 5% GelMA-HA. 
(d) Imaging of AL/N constructs shows a wider spread of fibrous-like structure and gaps. 





the formulation of bioinks and explored the efficacy of the biomaterials to support cell viability 
when used in combination with 3D bioprinting. Moreover, biomechanical analysis was 
performed to establish potential application of constructs and compare these to native heart 
tissue. 
4.1 Printability and Cell viability 
4.1.1 PEG-DA based bioinks 
 PEG-DA has been used for biomedical applications as it is non-toxic, presents easy 
manipulation and is biocompatible (Mazzoccoli et al., 2010). The easy manipulation of the 
material has been beneficial for cardiovascular research as heart structures (aortic valve and 
vessels) can be successfully obtained with this material at a relatively fast speed (Zhang et 
al., 2015a, Hockaday et al., 2012).  
This work aimed initially to investigate the ability of PEG-DA to support cell viability through a 
directly seeded bioprint method when coupled with Alginate. The printability of PEG-DA 
Alginate was fast, provided great shape fidelity and nozzle clogging was not observed with the 
bioink. However, abundant cell death was obtained with a direct seeded print. Upon further 
investigation, it was established that shear stress of the bioprinting process was not the cause 
of abundant cell death. It was found that the lack of PBS rinse on PEG-DA Alginate constructs 
greatly impacted cell viability. It has been previously shown that PEG degradation can be toxic 
to cells and PEG-variants despite being more biocompatible can also carry on toxic properties 
of PEG (Murali et al., 2015). Therefore, the elimination of the toxic properties of the biomaterial 
is necessary before cell implantation. 
PEG-DA intrinsically presents poor cell adhesion properties (Browning et al., 2014), coupling 
the biomaterial with Alginate and Gelatine is a method of enhancing cell attachment properties 
for constructs. It was observed that cells in PEG-DA Alginate (unrinsed) detached from  
constructs soon after death, by day 1. Cells from PEG-DA Gelatine, were also abundantly 
dead but these remained in the at day 1. This highlights the advantage of using animal-based 
bioinks over plant-based biomaterials. In animal-based biomaterials, cells demonstrate better 
attachment as the biomaterial naturally provides ECM signals and receptors to facilitate 
proliferation and the adhesion process. Alginate is negatively charged which impacts the ability 
to readily absorb proteins and it lacks ligands to which cells can bind to (Genes et al., 2004).  
From the findings mentioned above, the investigation for cell viability was tailored to minimise 
cytotoxicity (through PBS rinse before seeding the constructs with cells) and the addition of 




viability was greatly improved in constructs presenting over 50% viability consistently for 14 
days. There were no signs of cell migration to the bottom of the flaks.  
The cell implantation process was performed through the use of an orbital shaker which has 
proven to provide good cell spread and viability in 3D models. Although, the use of a bioreactor 
or spinner flask for cell seeding might have provided better cell attachment to constructs 
(Griffon et al., 2011). To further induce cell attachment to constructs and prevent cell migration 
to the bottom of the flask, low attachment plates were used throughout this experiment. 
However, research suggests that low attachment plates have no impact on the ability of cells 
to further attach to 3D constructs. Instead, cells are maintained in a suspended state and form 
spheroids over attachment to the biomaterial (Comley, 2017, Sant and Johnston, 2017, Shin 
et al., 2004). 
The abundant cell death obtained at day 21 for PEG-DA Alginate with collagen can be due to 
the poor shape fidelity of constructs upon the addition of collagen. PEG-DA extrusion is 
sensitive to salt concentration (Hockaday et al., 2012). Despite best efforts, the final bioink 
consistently clogged nozzles and extrusion was not possible. Instead, the bioink was extruded 
using a syringe and crosslinked after each ‘layer’ extruded. Consequently, the final constructs 
did not present passageways for nutrient exchange which is vital for cell survival within 3D 
models (Song et al., 2009). 
Other research groups have used PEG-DA Alginate with collagen successfully. These 
formulated various models including an aortic valve which was able to maintain cell viability 
for 21 days (Hockaday et al, 2012; Hong et al, 2015). Despite contact with one of the groups 
and following their guidelines to produce the bioink with collagen, I was still unable to produce 
a homogenous bioink to improve shape fidelity. 
4.1.2 GelMA based bioinks 
GelMA has been widely used for cardiovascular research for the fabrication of cardiac 
patches, myocardial tissue constructs and as a cell delivery vehicle for heart tissue (Klotz et 
al., 2016; Shin, et al, 2016). This biomaterial has great biocompatibility with cells as it contains 
an abundance of proteins and integrin-binding motifs that promote cells adhesion and 
migration. This study investigated shape fidelity of constructs dependant on GelMA 
concentration and the impact of different concentrations in cell viability. 
The poorest shape fidelity was demonstrated with 5% GelMA which proved unable to translate 
into the desired grid construct. Nonetheless, cell viability was analysed and this concentration 
presented the highest overall viability for the biomaterial, despite the constructs not presenting 




this concentration were not measured, but were appropriate for maintaining cell viability for 21 
days.  
5% GelMA was the only bioink to present spindle-shaped cells under microscopy. This is 
attributed to the final constructs presenting a flat structure compared to taller grid constructs, 
providing targeted focus in microscopy. Low concentrations of GelMA (≤ 5%) have shown to 
create spontaneous organisation of cells. In such environment cells have higher ability to 
elongate, migrate and form networks with neighbouring cells than in higher concentrations 
(Nichol et al., 2010).  
According to Loesnerr et. al, 2016 the recommended GelMA concentration for Mscs is 5% 
followed by UV exposure at 33 seconds in total. In this project, UV exposure was set to 20 
seconds per layer. This resulted in constructs able to withstand incubation and providing good 
results for cell viability compared to other concentrations and biomaterials. Also, the 
recommended cell seeding density for Mscs in 5% GelMA is 1x106 cells per ml, this parameter 
was used in this project. 
Despite presenting great cell viability, the printing process of the bioink was not smooth. GelMa 
is thermosensitive and the bioprinter used in this project lacks temperature management 
properties. That lead to a prolonged biopriting process; before printing each construct the 
viscosity of the bioink needed to be assessed (by eye) to determine if it was a viscosity which 
would create grid patterns, or if room temperature had set the bioink to a high viscosity which 
would not allow print. The same issue has been previously reported in literature, and it has 
been established that concentrations of GelMA lower than 20% present difficulties to create a 
uniform-3D model (Colosi et al., 2016, Pepelanova et al., 2018). 
5% GelMA was coupled with hyaluronic acid to improve printability of the bioink. This hybrid 
bioink provided good shape fidelity for constructs and a grid pattern was obtained. 
Interestingly, the addition of HA enabled the placement of the plate on ice after each layer 
printed to be bypassed. This gelation process uses the innate properties of gelatine that 
solidifies under 35ºC to obtain a good shape fidelity for each layer prior to UV exposure (Jaipan 
et al., 2017), but the process is time consuming.  
The cell viability for GelMA-HA was only 2.3% lower than 5% GelMA at day 21. The 
microscopy images for this biomaterial present cells in circular shapes. The cells in constructs 
are spread across different planes, therefore the focus of cells was hard to obtain. The same 
is true for the following biomaterials in this project. 
The printability of 7.5%, 10% and 20% GelMA was greatly improved, with the UV exposure 




10% still required placement of the plate in ice to stabilise each layer prior to crosslinking. 20% 
presented good dispersion and created a model which was robust.  
It was observed that as the concentrations for the bioink increased, the cell viability at day 21 
decreased. 10% GelMA presented a lower cell viability than 7.5% GelMA by approximately 
6.2% and in comparison to 5% GelMA it presented an approximate 29% lower cell viability. 
Progressing to a concentration of 20%, cell death was abundant from day 1. 
As mentioned before, a 5% concentration is ideal for mscs. Upon increase of the concentration 
to 10% the recommended cell model to use are chondrocytes and a 20% concentration is 
usually used for carcinoma cells and tumour studies (Lee et al., 2016). As the concentration 
increases, shape fidelity also increases but at the cost of a stiffer construct. Stiffer constructs 
tend to have a decreased pore size and cell migration becomes limited (Loessner et al., 2016) 
A study showed cell survival and attachment suffered a 50% decrease as the result of an 
increase in GelMA concentration from 5% to 20% (Wu et al., 2019). 
4.1.3 Alginate- nanocellulose 
This bioink provided easy printability in all nozzle sizes and no clogging issues. It was also the 
fastest printing process demonstrated among all bioinks. The viscosity of the biomaterial 
allowed all layers to be printed within constructs without intermittent crosslinking. Calcium was 
only added to constructs at the final stage of the process, prior to DMEM addition. 
Alginate can vary in molecular weight and viscosity but can be difficult to use in 3D constructs 
as it can become rigid throughout the printing process and without thermal properties in a 
bioprinter, the process can become tiresome. Nanocellulose provides high mechanical 
strength and thermal stability to alginate. A hybrid AL/N hydrogel presents increased cell 
proliferation compared to constructs composed solely of alginate (Siqueira et al, 2019). It has 
also been reported that nanocellulose improves controlled release of cells for alginate 
hydrogels (Nascimento et al., 2018). 
In this project, AL/N demonstrated over 80% cell viability through 21 days. These results 
validate the extensive literature on the high biocompatibility of alginate and cellulose (Tam et 
al., 2011, Lee and Mooney, 2012, Sun and Tan, 2013). However, cell migration began at day 
7 and by day 14 most cells were found in the bottom of the flask. The inability of constructs to 
adhere to cells for an extended period highlights the potential of alginate and cellulose based 
materials to be used as delivery tools (Nahar et al., 2017). In this case the constructs would 
not be expected to assimilate native structures; these would be expected to degrade after their 




The controlled release of cells is a valuable feature for cardiac tissue engineering. Alginate 
and nano-cellulose are great tools for cell, protein and growth factor delivery. Blood vessel 
formation has been detected in mouse models through the use of this hybrid biomaterial by 
the sustained release of vascular endothelial growth factor (Camci-Unal et al., 2014). 
Moreover, alginate has been used as cardiac patch for cardiomyocyte delivery and 
vascularisation in myocardial infarction mouse models. The results showed live 
cardiomyocytes, myofiber formation and an increased presence of gap junctions  even after 
complete patch degradation (Kaiser and Coulombe, 2015). These are promising features for 
CHD treatment. 
In regards to cell release, from the microscopy images obtained it can be said that a sustained 
cell release was maintained for 14 days. Alginate microspheres in drug delivery studies, were 
shown to release 80% of content within the first 100 hours, while alginate-cellulose 
microspheres released 20%. Both released a high surge of content upon construct 
degradation after 30 days (Lin et al., 2011). Other studies were able to maintain drug and cell 
release for three months with hybrid constructs (Lin and Dufresne, 2014, Leslie et al., 2013).  
To further investigate cell viability within alginate-nanocellulose, a 10 layered construct was 
created. Additionally, a low attachment well plate was used to observe if it would have an 
impact on cell migration. Some cells were found floating in media, outside constructs, from 
day 7. At day 14 all cells were in suspension and by day 21 all cells were dead. The results 
indicate that low attachment plates had no further impact on cell attachment to constructs, 
instead cells were kept in a suspended state and presented a circular shape. The abundant 
cell death can be due to the lack of nutrient in DMEM, as the medium was not changed for 14 
days for fear of losing cell migration occurance.  
In future, instead of leaving the constructs in the same medium, the constructs should be 
placed in a new well with DMEM every 48 hours. This will ensure that the cells in constructs 
are receiving nutrients while the cells (if any) in the previous flask can be used for a more 
accurate quantification on cell migration for AL/N constructs with more specific time points. 
This way lack of nutrients from DMEM could be ruled out as the potential cause of cell death. 
One of the aims of this particular investigation was to analyse cell viability in a bigger construct 
with intercalated gaps for nutrient exchange. Cell survival was maintained for 7 days within 
the constructs, however due to the propensity for cell migration this biomaterial was 
inadequate to carry out a 21-day analysis from the onset. GelMA would provide a good 
environment for cells in bigger constructs but the translation from code to design would be 
compromised due to the low viscosity of the bioink. This could lead to cell death as there would 




however the addition of collagen is necessary to maintain extended cell viability and 
unfortunately the printing process with this bioink was not successful. 
AL/N was also used to analyse cell spread from constructs to CorMatrix. The results for cell 
spreadibility within the material was poor. Most cells attached to the corners of the CorMatrix 
leaving the middle cell-free. This can potentially be attributed to the detachment of construct 
from CorMatrix after two days. CorMatrix is highly biocompatible and the reason why cells 
preferred to attach to the corner of the material is unknow. This behaviour is usually observed 
in hydrogel constructs which do not present appropriate inner networks to allow nutrient 
diffusion. In such cases, cells prefer outer parts of the constructs which allows them to be 
closer to medium. However, CorMatrix is 0.3 µm thick which falls within the possible nutrient 
exchange range, 200µm (Mosala Nezhad et al., 2016). 
4.2 Biomechanical properties  
The aim of this investigation was to design constructs with the potential to treat CHD. In tissue 
engineering it is important to create designs which are able to withstand their intended 
application  (Zhu and Marchant, 2011). Tensile strength and modulus of the biomaterials 
provide insight of their potential cardiovascular application. 
Overall the incorporation of cells significantly decreased the tensile strength and elasticity 
potential of constructs. It has been widely reported the decrease of strength in constructs after 
cell implantation, this can be attributed to degradation of material upon swelling and degree of 
crosslinking of materials prior to incubation (Billiet et al., 2014). However, there has been 
studies in which constructs demonstrated an increase in elasticity and/or stiffness upon cell 
implantation. This phenomenon is more common in hydrogels which have matured under 
bioreactor conditions, as in this environment cells are more likely to reorganise fibre interaction 
and produce higher levels of extracellular matrix. More often, constructs tend to decrease the 
tensile strength but increase their elastic potential overtime (Hu and Athanasiou, 2005, 
Wakatsuki and Elson, 2003). 
4.2.1 Alginate-nanocellulose 
AL/N presented the highest tensile strength and elastic potential compared to all other 
biomaterials in this study. The results demonstrated that AL/N constructs significantly 
decreased their tensile strength overtime with and without cells, but maintained its elastic 
potential. The decrease in mechanical properties in alginate-based bioinks is dependent on 
the alginate polymer used and method in which it was processed, but most alginate-based 
hydrogels show a significant decrease in mechanical properties within the first 7 days (Drury 




with and without cells. This day coincides with the migration of cells from constructs, but this 
factor is not mainly responsible for the biomechanical change as the same pattern is observed 
in constructs without cells. 
The constructs created in this investigation present positive potential for implantation. 
Constructs with (≈1823 kpa) and without cells (≈2981 kpa) presented superior tensile strength 
to human aortic and pulmonary valve structures at day 1 (Table 1). The average strength for 
AL/N constructs at day 21 without cells is approximately 28% lower than the tensile strength 
of a human aortic valve, ≈1740kpa. If cells are incorporated, this disparity increases by 
approximately 62% at day 21. In terms of elasticity, the constructs created in this study are 
not as extensible as the native heart structures mentioned above, independent of cell 
incorporation. The highest modulus results obtained was at day 1 (≈440 kpa), this represents 
a 2% modulus capacity of a human aortic valve. 
4.2.2 PEG-DA Alginate (without collagen) 
PEG-DA Alginate constructs were only tested without cells. The constructs presented second 
higest tensile strength at day 1, however by day 21 it showed tensile strength superior only to 
5% GelMA constructs which were the weakest.  Interestingly, this biomaterial contained the 
highest amount of photo-initiator, 1% Irgacure 2959, and the shortest UV exposure per layer. 
Higher concentration of photo-initiator helps biomaterials to set with shorter UV exposure 
times, but often these lead to stiffer constructs and cell death (Kandhaker et. al, 2016). 
Overtime the elastic potential for PEG-DA Alginate was reduced but presented similar 
potential to GelMA based constructs.  
Hockaday et. al, 2012 analysed stress- strain and modulus relationship for various 
concentrations of PEG-DA Alginate constructs, including the same bioink used in this study 
without collagen. The biomechanical tests carried in that study were performed right after 
bioprint and crosslinking of samples which differs from this study as measurements were 
carried one day after bioprint. Hockaday obtained 74.6 ± 1.5 kpa modulus for 8mm diameter 
and 7mm width samples, created with biopsy punches. In this study, constructs were 7.5 x 15 
x 2 mm in size and demonstrated nearly twice more extensibility potential at day 1 (145.2 ± 
49.75 kpa). 
Chen et. al, 2018 analysed the tensile strength PEG-DA constructs 70 x 20 x 0.5 in size. These 
constructs presented 130-fold higher tensile strength after print (18980 ±  1.11kpa) compared 
to PEG-DA Alginate constructs created in this study. In Chen’s study, 3% of 2,4,6-trimethyl 
benzoyl diphenyl phosphine oxide was used as photoinitiator and their samples were cured 
under UV for 1 minute twice (Chen et al., 2018). These features are considerably different 




Overall the biomechanical results obtained in this study demonstrate great potential for 
cardiovascular use. The tensile strength for PEG-DA Alginate at day 1 (1956 ± 119.1 kpa) 
without cells demonstrated slightly superior results to the average tensile strength of aortic 
valves in human hearts, 1740 ± 0.29 kpa (Table 1). However, at day 21 the tensile strength 
demonstrated by constructs were 30-fold weaker than a human aortic valve.  The constructs 
in this study demonstrated to be less extensible and compliant than aortic and pulmonary 
valves for both humans and pigs, but demonstrated similar extensive potential to more specific 
anatomical regions such as aortic leaflets (≈54kpa), aortic (≈140-180 kpa) and pulmonary root 
(≈50-85 kpa) in humans (Hockaday et al., 2012, Mavrilas and Missirlis, 1991). 
PEG is a synthetic biomaterial which can be modified to present more suitable mechanical 
strength, material porosity and degradation rates. PEG hydrogels have been used for cardiac 
tissue implants and have prevented LV dilation and remodelling in mice. Moreover, it has been 
shown to promote blood vessel formation  and tissue growth when used in combination with 
cells (Domenech et al., 2016). Due to the extreme versatility of this material, the constructs 
created in this study can be further optimised to increase tensile strength and elasticity to 
better suit the potential for heart use. That said, the constructs show positive potential to be 
used as cardiac patches to correct holes in heart of CHD patients. 
4.2.3 GelMA  
Gelatine is denatured collagen, but the material still contains crucial factors for cell adhesion 
and nutrient absorption. The addition of methacrylate to the substance allows further 
mechanical manipulation of the biomaterial through photo-crosslinking (Zhu et al., 2019). This 
study has shown a consistent record of good cell viability for GelMA concentrations ranging 
from 5% to 10%. However, the biomechanical properties for the constructs have shown to 
vary significantly dependant on GelMA concentration. 
5% GelMA presented printability difficulties and inability to create a 3D grid construct. 
Consequently, this biomaterial presented significantly lower tensile strength compared to all 
other materials at day 1 without cells and remained the weakest overtime. As for modulus, 
initially this concentration presented similar elasticity to all other biomaterials except AL/N, but 
overtime the biomaterial demonstrated inferior elastic potential to all. As previously mentioned, 
lower concentrations of GelMA present lower shape fidelity and consequently poorer 
mechanical properties. There are two main ways in which research improves the mechanical 
properties of GelMA: 1. Include thermoplastic co-depostion or mixing hyaluronic acid and 2. 
Increasing GelMA concentration (Pepelanova et. al, 2018). In this study we explored both. 
The use of hyaluronic acid evidently provided benefits for shape fidelity of the constructs. This 




to 5%GelMA. Moreover, the addition of HA allowed biomechanical properties measurements 
with cells which was not possible with 5% GelMA as the biomaterial was too weak to 
manipulate into biomechanical testing. The increased concentration GelMA constructs (7.5% 
and 10%) presented similar elastic potential to 5% GelMA-HA overtime with and without cells. 
Tensile strength among increased concentration GelMA groups and 5% GelMA-HA with cells 
demonstrated similar strengths, but without cells GelMA-HA presented significantly lower 
strength overtime. The addition of cells to constructs lowers tensile strength as demonstrated 
in the previous experiments (Drury et al., 2004, Vedadghavami et al., 2017), this study 
presented the same characteristics. However, as 7.5% and 10% GelMA constructs 
demonstrated over 90% decrease in tensile strength from when analysed without cells at day 
1 to day 21 with cells, GelMA-HA constructs presented a slightly lower disparity, 84%. This 
potentially suggests that HA is a beneficial addition to biomaterials as it helps constructs 
maintain higher tensile strength overtime.  
During GelMA preparation various factors can influence its mechanical properties: degree of 
functionalisation of amino acids, source of gelatine and crosslinking manipulation used within 
experiment. Crosslinking manipulation can vary on the type of photo-initiator used, 
concentration of photo-initiator and light intensity for crosslink (O'Connell et al., 2018). 
 In this study, Irgacure-2959 was used on all biomaterials which were chemically crosslinked, 
but the concentration of the photoinitiator was maintained only for GelMA-based biomaterials. 
The crosslinking time for 10% GelMA constructs was 15 seconds per layer while all other 
concentrations were exposed to 20 seconds of UV. Although it has been shown that UV 
exposure time can cause a decrease in cell viability, these changes are dependant on GelMA 
concentrations and intensity received from constructs by the 365nm UV used. These factors 
are translated into this study as 10% GelMA has lesser UV exposure time, but lower cell 
viability overall within GelMA-based  constructs. In terms of biomechanical properties, 
constructs tend to become stiffer with higher concentration and UV exposure time (Pahoff et. 
al, 2018) but in this study tensile strength was maintained slightly lower for 10% GelMA 
constructs in comparison to 7.5% GelMA while the elastic potential was slightly higher than 
other GelMA-based biomaterials overtime. 
GelMA has presented similar biomechanical properties to PEG-DA Alginate with the 
advantage of a good cell viability record. Therefore, these constructs have potential use for 
CHD treatment as they present alike properties to certain anatomical heart regions such as 




4.3 Limitations of this study 
4.3.1 Alternative imaging methodologies 
The imaging used in this study could be improved by enhanced microscopy techniques to 
provide a clear 3D positioning of cells. The main microscope used in this study, Zeiss Axio 
Observer z1, can provide greater depth of field by using Z-projection/ stacks. This method 
captures various images from the object at different distances providing a clear- focused 
image. In this instance, the 3D positioning of cells can be clearly seen instead of unfocused- 
blurred images in the background which were obtained (Sartori et al., 2007). 
Confocal microscopy is an additional technique that allows improved 3D imaging for 
hydrogels. In fluorescence microscopy the constructs receive an even spread of light, all parts 
of a sample can be excited simultaneously which results on the fluorescence captured by a 
photodetector. The focal plane for imaging is wider which can result on blurred background 
due to surrounding reflection. Confocal microscopy operates by single point illumination and 
has a narrower focal plane. Fluorescence gathered by the sample is filtered through a pinhole 
which rejects light from areas outside the focal plane. The point of illumination can be as small 
as the wavelength of light, 0.5 µm, which helps create a clear image (Nwaneshiudu et al., 
2012). 
4.3.2 Proliferation assessment 
5% GelMA constructs presented an increase on live cells in comparison to day 1, these results 
show that the biomaterial is highly capable of supporting viability. However, these do not 
provide information on the proliferative state of cells within the constructs. 
A well-established method for cell proliferation assessment in hydrogels is metabolic activity 
assays (Bradshaw et al., 2014; Gering et al., 2019; Kisiday et al., 2002; Schmalz et al., 2014; 
Tyliszczak et al., 2017). Cell proliferation causes lactate dehydrogenase to increase activity 
during proliferation and this causes a decrease on tetrazolium salts, this change in activity 
allows read of absorbance on a spectrophotometer and microplate reader to determine cell 
proliferation. Common tetrazolium salts are MTS, MTT and XTT; these vary in sensitivity and 
toxicity to cells. MTT is used as enpoint analysis as it is toxic to cells while the other assays 
can be used in continuing experiments (Bradshaw et al., 2014; Gering et al., 2019; Kisiday et 
al., 2002; Schmalz et al., 2014; Tyliszczak et al., 2017). 
4.3.3 Degradation analysis 
Due to the numerous applications hydrogels can provide (eg. drug or cell delivery, tissue 
fabrication), the mechanism of degradation for the biomaterial in use needs to be considered  




degradation: 1. Hydrolysis and enzymatic degradation. 2. Introduction biofunctional molecules 
in crosslinking to aid degradation in vivo (Lee et al., 2004). This study did not explore rate and 
method of degradation of the different hydrogels created. That would provide additional 
information on the application of constructs and insight for refinement of hydrogel production 
aiming for a controlled degradation. 
5 CONCLUSION 
AL/N demonstrated high biocompatibility and superior tensile strength and modulus than all 
other biomaterials in this study. However, complete cell migration at day 14 highlights the 
potential for cell delivery rather than a long-term structure. PEG-DA Alginate presents 
advantageous features for tissue engineering as it is a synthetic biomaterial which can be 
more easily manipulated to modify biomechanical properties. However, in this investigation it 
presented similar tensile strength and modulus to GelMA constructs while presenting inferior 
cell biocompatibility. GelMA constructs presented great cell viability through 21 days 
maintaining great cell attachment. Tensile strength and modulus were inferior to results 
obtained by AL/N, however this material shows more potential for a long-term structure than 
the others. 
Though few tensile strength and modulus results presented minor similarities to native heart 
structures. It is important to to highlight that most constructs presented a drastic reduction in 
strength and modulus once cells were incorporated. Therefore, the constructs developed in 
this study are best suited as cell delivery vehicles rathen than long-term structures. 
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